Piperine disrupts the OFF state of the resting thick filament of rat skeletal muscle, enhancing dynamic contractility in a fibre‐type‐dependent manner Authors: Daniel Z Kruse, Jon Herskind, Michel N Kuehn, Annika J Klotz, Anthony L Hessel, Kristian Overgaard Published: 2026 ABSTRACT AbstractAbstractThe myosin‐containing thick filament has been shown to alter its resting structure in response to multiple diseases and therapeutics. Changes in thick filament resting structure are caused by myosin heads transitioning between ordered and disordered OFF conformational states. Functionally, this modulation of thick filament structure is a key regulatory step in muscle contraction and a promising therapeutic target. The availability of disordered myosin heads governs dynamic contractility, which is critical to physical function and well‐being. At present, there is a lack of compounds favouring this disordered state in resting skeletal muscle. Piperine is a molecule known to bind to myosin and increase submaximal isometric contractility in fast and slow skeletal muscle. However, the effects on dynamic contractility and the underlying mechanism responsible for the observed effects in skeletal muscles remain unclear. Here, we used fibre small‐angle X‐ray diffraction and intact‐muscle ex vivo contractility experiments to determine the effects of piperine on resting myosin structure and dynamic contractility in fast and slow rat muscles. X‐ray diffraction data suggest that piperine promotes a priming of myosin in resting skeletal muscle from an ordered OFF state to a disordered OFF state, increasing the availability of myosin heads for force generation. Functionally, piperine substantially enhanced submaximal dynamic contractility in both muscle types, while only leading to improvements in slow muscle during maximal electrical stimulation. These findings establish piperine as a tool for priming the thick filament in skeletal muscle, highlighting muscle‐type‐specific effects of thick‐filament modulation on the recruitment of the contractile reserve capacity. Key points Piperine is a compound known to bind to skeletal muscle myosin and enhance isometric contractility in fast and slow muscles, but its effect on dynamic muscle function and the underlying molecular mechanism remain unknown.We show that piperine disrupts the ordered OFF state of the myosin‐containing thick filament in resting fast and slow skeletal muscle, which likely explains the effect of piperine on contractile function.Piperine substantially increases contractile power of both fast and slow skeletal muscles at low‐frequency stimulation; however, it only enhances power in slow skeletal muscle at high‐frequency stimulation.Our data reveal potentiation of dynamic contractility with fibre‐type‐dependent magnitudes in response to piperine‐induced priming of the resting thick filament, which is a phenomenon requiring further investigation.Dynamic contractility drives locomotion in vivo; therefore, thick‐filament priming may ultimately be exploited in the treatment of diseases characterised by skeletal muscle weakness. Keywords: contractile power, force–velocity curve, skeletal muscle phenotype, skeletal‐muscle myosin, small‐angle X‐ray diffraction, thick‐filament activation Introduction Recent advances in muscle physiology have highlighted the myosin‐containing thick filament as an important regulator of muscle contractility (Brunello & Fusi, 2024; Hill et al., 2026; Irving, 2017; Linari et al., 2015). Therefore, the thick filament also serves as a promising therapeutic target for restoring contractile impairments in cardiac and skeletal muscle (Claassen et al., 2023; Lehman et al., 2022). In this perspective, modulation of dynamic muscle function is of particular interest because it is paramount to physical functioning and well‐being (Freitas et al., 2024). Resting myosin heads exist in an equilibrium between the non‐actin‐bound ordered and disordered OFF states. Upon contraction, a portion of resting myosin heads move into an actin‐bound ON state. The ordered OFF state is characterised by myosin heads being tightly ordered near or in the helical tracks of the thick filament backbone. The disordered OFF state is characterised by less ordering and closer proximity of myosin heads to actin. Disordered OFF heads more probably engage with actin upon calcium release and thereby are crucial for muscle performance (Dutta et al., 2023; Huxley & Brown, 1967; Reconditi et al., 2011; Tamborrini et al., 2023; Woodhead et al., 2005). Pharmacological molecules have shown promise in treating contractile impairments in cardiomyopathies by modulating the OFF‐myosin states (Lehman et al., 2022; Olivotto et al., 2020; Voors et al., 2020), at the same time as affecting skeletal muscle myosin with much lower affinity (Governali et al., 2020; Karimi et al., 2024; Lindqvist et al., 2019; Nagy et al., 2015; Potoskueva et al., 2025; Radke et al., 2014). Hence, there is a lack of molecules specifically designed to prime the thick filament of skeletal muscle by promoting the disordered OFF state. A potential tool for investigating priming of the thick filament in skeletal muscle is the compound piperine, an alkaloid found in black pepper (Nogara et al., 2016). Piperine has been shown to bind to the myosin regulatory light chain (RLC) (Tolkatchev et al., 2018), a domain known to regulate muscle contractility by altering myosin head conformations (Craig & Padrón, 2022; Vandenboom, 2016). Piperine has also been shown to activate the transient receptor potential vanilloid 1 (TRPV1) ion channel (Dong et al., 2019; McNamara et al., 2005; Okumura et al., 2010) and thus potentially alter resting and/or contraction‐induced myoplasmic Ca2+ levels. However, using rodent skeletal muscle, a recent study (Herskind et al., 2024) showed that piperine does not affect resting or contraction‐induced myoplasmic Ca2+ levels. Furthermore, Herskind et al. (2024) showed that piperine increased myofibrillar Ca2+ sensitivity, a fundamental determinant of muscle contraction, in both fast and slow skeletal muscle fibres. Interestingly, piperine also enhances Ca2+ sensitivity in cardiomyocytes (Jani & Ma, 2025), and this effect was ascribed to a disruption of the ordered OFF‐myosin state (Jani et al., 2024). Together, these studies suggest that piperine elicits a myosin‐mediated contractile effect, which is present in both cardiac and skeletal muscle. However, mechanistic explanations remain speculative. Herskind et al. (2024) demonstrated that piperine increases isometric twitch force and force of unfused isometric contractions in both fast‐ and slow‐twitch dominant rat skeletal muscles. However, pure isometric contractions do not adequately reflect all the contractile characteristics of muscles in vivo; therefore, examination of muscles contracting dynamically is warranted. Concentric muscle performance in intact muscle can be described by the force–velocity curve (Hill, 1938 ; Huxley, 1957), and parameters of the curve can be exploited to study contraction mechanisms. In this regard, the structure of the thick filament is highly dependent on the degree of external load because strain regulates the fractions of non‐actin‐binding (OFF) and actin‐binding‐sensitive (ON) myosin heads, a phenomenon known as mechanosensing (Brunello & Fusi, 2024; Fusi et al., 2016; Hill et al., 2022; Irving, 2017; Linari et al., 2015). During high‐velocity shortening at zero load, a small fraction of constitutively disordered‐OFF myosin motors binds to actin to facilitate contraction (Fusi et al., 2017; Linari et al., 2015). By contrast, during contractions against higher relative loads, the thick filament structure is disordered by strain‐mediated mechanosensing (Fusi et al., 2016; Linari et al., 2015). Thus, an important modulator of the force–velocity curve is the load‐dependent priming of the thick filament in a complex response to the varying relative loads. Accordingly, Piazzesi et al. (2007) showed that the fraction of actin‐bound ON myosin heads was the major determinant of shortening velocity because the fraction decreased as velocity increased. Expanding on this, it is still unknown how an increased fraction of disordered OFF myosin heads in resting skeletal muscles will affect dynamic contractility across varying relative loads. Answering these unknowns is essential to addressing the therapeutic potential of skeletal‐muscle thick‐filament priming in the treatment of debilitating weakness as a result of myopathies (Karimi et al., 2024; Lindqvist et al., 2019; Ochala et al., 2010). Accordingly, in the present study, we aimed to test the hypothesis that the underlying cause of piperine's force‐potentiating effects in both fast and slow skeletal muscle is the priming of the resting thick filament of skeletal muscle by a disruption of the ordered OFF‐myosin configuration. Furthermore, to investigate the extent to which piperine could enhance contractile power in dynamic contractions in muscles containing predominantly fast‐ and slow‐twitch fibres, respectively. Methods Ethical approval No experiments were performed on live animals, and handling of the animals and the death of the animals were carried out by trained personnel. All experiments were performed using isolated hindlimb muscles from 4‐week‐old female Wistar rats (Janvier Labs, LeGenest‐Saint‐Isle, France) as described below. All procedures were executed according to the local Danish Animal Welfare Legislation and the European Animal Welfare Regulations (Directive 2010/63/EU). Animals and muscle preparations Animals were housed under a 12/12 h light/dark photocycle at the Laboratory Animal Core Facility at the Department of Biomedicine at Aarhus University, Denmark. Animals were allowed ad libitum access to food and water and were kept at the animal facility for ∼1 week before experiments. Animals were killed by cervical dislocation followed by instant decapitation. Isolated extensor digitorum longus (EDL) and soleus muscles were used for all experiments because of their predominance of fast‐ and slow‐twitch fibres, respectively (Cornachione et al., 2011). For the determination of resting thick‐filament structure by small‐angle X‐ray diffraction (MyoXRD) experiments, glycerol‐permeabilised bundles of fibres from both EDL and soleus muscles were used (Hessel, Kuehn et al., 2024). Intact muscles were dissected and tied to small sticks to maintain fixed length during submersion in relaxing solution [concentrations in mm: potassium propionate 91.2, MgCl2 3.6, Na2‐ATP 2.5, EGTA 7.0, imidazole 20.0 and Halt™ protease inhibitor cocktail 1% (Thermo Fisher Scientific, Waltham, MA, USA), pH 7.0 at room temperature]. Permeabilisation was achieved by placing the muscles in relaxing solution at 4°C for 8 h on a rotator and then transferring them to a storage solution composed of the relaxing solution and glycerol (40/60% volume), where they were stored overnight on a rotator at 4°C. Hereafter, muscles were stored for 2–4 weeks at −20°C, before being transferred to the experimental facility on ice. For mechanical experiments, intact EDL and soleus muscles were dissected while being moistened in Krebs‐Ringer (KR) buffer (concentrations in mm: NaCl 122.13, KCl 2.84, CaCl2 1.27, MgSO4 1.19, KH2PO4 1.19, NaHCO3 25.06 and d‐glucose 5.0; pH 7.2–7.4 at room temperature) and mounted in the experimental setup immediately after. Assessment of resting thick‐filament structure using small‐angle X‐ray diffraction Resting thick filament structure was determined in permeabilised bundles of EDL (n = 28 bundles from seven animals) and soleus (n = 20 bundles from six animals) (total animals: n = 10) fibres at 27°C before and after 20 min of incubation in 50 µm piperine (catalog. no. P49007; Sigma‐Aldrich, St Louis, MO, USA) (dissolved in dimethyl sulfoxide, DMSO) (Herskind et al., 2024; Jani et al., 2024). On the experimental day, muscles were vigorously washed in cold relaxing solution to remove glycerol. Then, 2–6 mm long bundles of ∼5–15 muscle fibres (bundle width: ∼0.4 mm) were dissected, and silk suture knots (sizing 5‐0) were tied at both ends. Finally, bundles were mounted onto a specially designed muscle mechanics rig for MyoXRD (Hessel et al., 2022) at a sarcomere length (SL) of ∼2.7 µm, corresponding to the optimal length of force production (L o) (Gong et al., 2022). Before experiments, laser diffraction was used away from the beamline to establish SLs based on slack length of the bundles, and then the attached motor was used to stretch to the desired starting length based on a 1:1 ratio of sample length to SL (Hessel et al., 2026). MyoXRD patterns were collected using the small‐angle instrument on the P03/MiNaXS beamline (PETRA III; DESY, Hamburg, Germany) (Buffet et al., 2012). Bundles were manually aligned and targeted with the X‐ray beam using an inline camera, which also allowed visual control of sample quality during experiments. For each condition, the collimated, unattenuated beam scanned the sample along its long length to produce ∼25–50 images (50 µm displacements) with 100 ms exposure per image, which in pilot studies produced negligible radiation damage (>300 ms required). No part of the sample was exposed more than once, and line scans for each condition were performed on homogeneous areas of the top and bottom halves of the bundles, respectively. The X‐ray beam (∼0.103 nm wavelength) was focused to ∼20 × 20 µm on the sample, with an incident flux of 5 × 1011 photons per second. Diffraction patterns were collected by a Pilatus (2M; Dectris, Baden, Switzerland) detector (172 × 172 µm pixel size). Data was collected during two separate beamline runs, with the sample‐to‐detector distance being 9.8 and 4.6 m for the first and second data collections, respectively. Real space was calculated using the 100‐diffraction ring of silver behenate (d 001 = 5.8380 nm) as a calibration standard before each data collection. A subgroup of EDL bundles (n = 9 bundles) was tested at SL 2.4 and 2.7 µm before and after piperine incubation, using a passive ramp‐hold protocol as previously described (see Appendix, Doc. A1 and Table A1) (Hessel, Engels et al., 2024). Analysis of images from MyoXRD experiments Initially, MyoXRD patterns were reduced and prepared for analysis in a custom‐made Python program (https://www.python.org) and the open‐source MuscleX data reduction and analysis package (BioCAT; Argonne National Laboratory, Lemont, IL, USA) (Jiratrakanvong et al., 2026). For each individual image, the intensities of reflections were normalised to the corresponding X‐ray intensity collected at the beamstop. The resultant intensity distribution background was subtracted via a custom code in Python using a convex hull algorithm such as MuscleX. Following, images were analysed using MuscleX. In brief, images in a line scan were aligned, mean‐merged together and quadrant‐folded to improve signal‐to‐noise. The Equator routine of MuscleX was used to calculate the equatorial intensity ratio (I 1,1/I 1.0) and the inter‐thick‐filament lattice spacing (d 1,0). To determine the equatorial intensities (I 1,0 and I 1,1), the intensities along the equatorial axis of the image were integrated (± 0.005 nm−1 on either side of the equatorial axis). This was followed by 1,0 and 1,1 fitting Gaussian curves to the 1,0 and 1,1 reflections, respectively. Spacings and intensities were calculated via the maximum Gaussian peak and area under the Gaussian curve, respectively. The equatorial 1,0 and 1,1 reflections were fitted with two independent Gaussians, each with three degrees of freedom. The z‐disc reflection, which can arise in fast‐twitch fibres, is very weak in permeabilised preparations and was generally not separable from the 1,1 reflections in our data. Hence, our 1,1 Gaussian fit probably includes the z‐disc reflection, which leads to slightly larger intensity ratios across the experiment. Spacings of the meridional M3 and M6 reflections (S M3 and S M6) were extracted by the projection‐traces routine in MuscleX. The intensity of the M3 reflection (I M3) was calculated by integrating in the reciprocal radial range ∼0 ≤ R ≤ 0.032 nm−1 for the M3 reflections. Hereafter, integration limits on the meridional axis were 0.066 ≤ R ≤ 0.074 nm−1 and 0.136 ≤ R ≤ 0.144 nm−1 for the M3 and M6, respectively. The spacing and intensity of each reflection were calculated automatically from these. Gaussian fits with fit errors above 10% were excluded. Experimental setup for contractile experiments For contractile experiments, contralateral whole EDL muscles (n = 6 animals, bodyweight 111 ± 8 g and muscle weight 41 ± 8 mg) and soleus muscles (n = 6 animals, bodyweight 91 ± 16 g and muscle weight 47 ± 12 mg) were placed in oxygenated chambers filled with 100 mL of standard KR buffer at 30°C and constantly bubbled with a gas mixture of 95% O2 and 5% CO2. As illustrated in Fig. 1A , muscles were mounted in the contractile setup (Model 305 Dual Muscle Lever; Aurora Scientific, Aurora, ON, Canada). This setup allowed for simultaneous experiments on contralateral muscles, in which contraction force and muscle length were measured during electrically induced contractions. After mounting in chambers, muscles were stimulated to elicit a brief isometric tetanus to test the integrity of the knots, and then they rested for 30 min. Muscles were stretched to a muscle length (L o) that corresponded to maximal force generation during triplet stimulation, and thereafter the muscles rested for an additional 20 min before the experiments began. Contractile forces were checked during the initial protocol to assess the stability of the muscle preparations. Isometric and dynamic muscle contractions were evoked by electrical stimulation with a computer‐controlled lever arm imposing various external loads (DMC 5.500; Aurora Scientific). All contractions were induced by supramaximal electrical stimulation via field stimulation by two platinum plate electrodes (pulse duration = 0.2 ms; 1 A; 16 V cm−1) (Jakobsgaard et al., 2022). Experimental setup and main protocol for whole‐muscle contractility experiments A, contralateral pairs of intact fast (extensor digitorum longus, EDL) or slow (soleus) rat skeletal muscles were dissected and mounted in the illustrated setup. B, the main experimental protocol used to test the isolated effects of piperine (vs. vehicle), and the ability to wash‐out the effects of piperine, on dynamic contractility via two distinct incubation sequences: (a) and (b). Dynamic contractility was assessed by performing force–velocity (FV) tests at baseline (FV1), after a 1 h incubation (FV2), and after a second 1 h incubation (FV3). The illustrations are made using bioRender.com and Microsoft PowerPoint. Main experimental protocol for contractile experiments The main experimental protocol (Fig. 1B ) compared the isolated effects of vehicle and 50 µm piperine treatment on dynamic contractility in contralateral pairs of fast (EDL) and slow (soleus) rat muscles. Dynamic muscle function was assessed by performing force–velocity tests at baseline (FV1) and after two 60 min incubations (FV2 and 3). Isometric contractility was monitored during the 60 min incubation by twitch (2 Hz), unfused tetanic (EDL, 50 Hz for 0.3 s; soleus, 20 Hz for 2 s), and fused tetanic (EDL, 150 Hz for 0.2 s; soleus, 80 Hz for 2 s) contractions induced every 20th and 10th min for EDL and soleus muscles, respectively. These three isometric contraction types were tested as a result of their distinct underlying features of intracellular Ca2+, summation of forces from subsequent action potentials and thick‐filament priming level (Baylor & Hollingworth, 2003; Brunello & Fusi, 2024). Piperine was dissolved in ethanol 96%, with ethanol (vehicle) making up 0.1% of the total buffer volume. Assessment of low‐ and high‐frequency dynamic muscle function during force–velocity testing Isotonic low‐ and high‐frequency (EDL, 60 and 150 Hz; soleus, 20 and 80 Hz, respectively) force–velocity curves were determined using the afterload method, as previously described (Kristensen et al., 2019; Kristensen et al., 2020). Each force–velocity curve was determined by measuring the maximal shortening velocity (mm s−1) against seven relative load levels (in this order: 15%, 80%, 27.5%, 40%, 5%, 100% and 60% of maximal low‐ and high‐frequency isometric force, respectively). To allow for satisfying recording of length changes and shortening velocities during force–velocity testing, contractions were performed using varying durations of stimulation trains at the various percentages of isometric maximum force. Specifically, stimulation trains for EDL were 0.3 s for contractions at 100% (isometric) and 0.2 s for all other contractions. For the soleus, stimulation trains were 0.6 s for low‐ and high‐frequency contractions from 5%–27.5% and 5%–80%, respectively, 1.2 s for low‐frequency contractions from 40%–80%, and 2 s for low‐ and high‐frequency contractions at 100% (see also exemplary force‐ and length traces in the Appendix, Fig. A1). Low‐ and high‐frequency contractions at the same relative loads were induced 5 s apart, starting with the low‐frequency contraction to avoid post‐tetanic potentiation artefacts. Contractions at subsequent loads were interspersed by 10 min of rest. Analysis of data from contractile experiments All contractile data (force and length) were recorded at 2000 Hz and filtered using a Butterworth filter with a cutoff frequency of 30 Hz. Data was analysed using custom‐made MATLAB software (MATLAB R2024a; MathWorks Inc., Natick, MA, USA) (Kristensen et al., 2019). Force kinetics and shortening velocity were measured over a 0.01 s average. Isometric contractions were analysed for the following outcomes: peak active force (peak total force – passive tension) (mN), peak rate of force development (RFD) (N s−1) and half‐relaxation time [twitch, time (ms) from peak to half‐force; unfused and fused tetani, time (ms) from last stimulus to half‐force]. Relaxation after fused tetani was further divided into an initial slow (linear) phase, followed by a fast (exponential) phase using a custom‐made MATLAB code. For each contraction, the inflection point between the slow and fast relaxation phases was automatically detected using piecewise linear fitting. Thereafter, linear fits (last stimulus to inflection point, mean R 2 > 0.78) (1) and single‐exponential fits (inflection point to 5% of peak force, mean R 2 > 0.97) (2) were made. We report the slope of the linear fit (k slow) normalised to the peak force (s−1) and the rate constant of the exponential fit (1/tfast = s−1). During dynamic contractions, the contractile force and the simultaneous shortening velocity were analysed. The contractile force (mN) during shortening was analysed as the steady force of the force plateau during shortening. Maximal shortening velocity (mm s−1) was analysed as the largest negative change in muscle length during a 0.01 s time interval. From measured force and shortening–velocity values, force–velocity curves were fitted (mean R 2 > 0.98) using Hill's force equation (3) and the corresponding power curves (force × velocity) were fitted using Hill's power equation (4): In the above equations, F o is the measured maximal isometric force, V is the shortening velocity, and a and b are constants. The maximal unloaded shortening velocity (V max, in mm s−1) and maximal isometric force production (F max, in mN) were estimated from the extrapolation of these curves. Likewise, the curvature of the force–velocity curve (a/F o, in a.u.) and the maximal power production (P max, in mJ ms−1 = mW) were estimated. Statistical analysis Descriptive values are presented as the mean ± SD, whereas differences (absolute and percentage) are presented as the mean difference followed by the range of the 95% confidence interval. X‐ray values are reported as model‐based mean ± observed SD. P < 0.05 was considered statistically significant, and except for X‐ray analyses (Rstudio, version 4.5.1; Posit, Boston, MA, USA), all statistical analyses and figures were made using Prism, version 10.2 (GraphPad Software Inc., San Diego, CA, USA). Data were assessed for normality by visual inspection of quantile–quantile (QQ) plots, and assumptions of equal SD values were tested by F tests. To meet assumptions of normality, some MyoXRD outcomes (EDL: I 1,1/I 1,0, S M3 and I M3; soleus: I 1,1/I 1,0) were log‐transformed for statistical analysis. Changes in MyoXRD outcomes were analysed using linear mixed‐effects models with treatment (baseline/piperine) as fixed effect and sample as random effect. Parameters were estimated using restricted maximum likelihood and Satterthwaite approximation. Changes in isometric contractile function during incubations were analysed by two‐way analysis of variance (ANOVA) and mixed‐effects models (as a result of a missing value) in the soleus and EDL muscles, respectively. The main effects of treatments (piperine, vehicle and wash‐out), time point (soleus: 0, 10, 20, 30, 40, 50 and 60 min of each incubation; EDL: 0, 20, 40 and 60 min of each incubation) and their interaction (treatment × time point) were analysed, and changes from baseline between treatments at specific timepoints were tested in post hoc analyses. In relation to dynamic contractility, the main effects of treatment (piperine and vehicle), load (5%, 15%, 27.5%, 40%, 60%, 80% and 100% of initial F max) and their interaction (treatment × relative load) were analysed by two‐way ANOVAs (mixed‐effects models for EDL) with subsequent Bonferroni‐corrected post hoc tests analysing relative differences in measured contractile power at the relative loads compared to baseline. Relative changes in isometric forces were compared by paired t tests. Also, estimates of V max, curvature and P max from the Hill equations were analysed by paired t tests comparing relative changes from baseline between muscle pairs. Results Piperine disrupts the ordered OFF state of the thick filament in resting slow‐ and fast‐twitch fibres To determine the currently unknown molecular changes that can explain the previously reported piperine‐induced potentiation of isometric force of both slow and fast skeletal muscle (Herskind et al., 2024), we assessed the resting thick filament structure before and after piperine treatment using MyoXRD (Fig. 2A and B ). Schematic of the resting thick filament structure assessed by fibre small‐angle X‐ray diffraction (MyoXRD) experiments A, representative MyoXRD patterns with reflections originating from longitudinally (meridional) and transversely (equatorial) repeating sarcomeric structures. The representative image is split vertically, showing a baseline (pre) image on the left and a post‐piperine image on the right, from a single soleus and a single extensor digitorum longus (EDL) bundle in the top and bottom halves, respectively. Each quadrant of the representative image is a merge of 25–50 diffraction images from the same bundle, acquired during a line scan with 100 ms exposures and a sample‐to‐detector distance of 9.8 m. B, an illustration of the sarcomeric structures from which the diffractions arise. Red lines show the primary origin of the reflection. The following outcomes were extracted: the equatorial intensity ratio (I 1,1/I 1,0), the spacings of the M3 and M6 reflections (S M3 and S M6), the intensity of the M3 reflection (I M3) and the inter‐thick‐filament lattice spacing (d 1,0). The 1,0 reflection arises from the myosin‐containing thick filament (blue) in isolation, where the 1,1 reflection arises from both the myosin‐containing thick filament (blue) and the actin‐containing thin filament (orange). The M3 and M6 reflections primarily arise from the repeating arrays of myosin heads (green) (Koubassova et al., 2025). The illustration in (B) was made using bioRender.com. Fast‐twitch fibres The equatorial intensity ratio (I 1,1/I 1,0) arises from the mass distribution between the thin (I 1,1) and thick (I 1,0) filaments. An increase in I 1,1/I 1,0 is the result of an increased mass transfer of the thick filament towards the thin filament, as seen in contracting muscle. Piperine increased the I 1,1/I 1,0 in fast‐twitch EDL fibres compared to baseline (baseline: 0.54 ± 0.21 (model‐based mean ± observed SD) vs. piperine: 0.85 ± 0.55, P = 0.001) (Fig. 3A ), indicating a mass movement (i.e. myosin heads) from the thick filaments towards the thin filaments. The spacing and intensity of the meridional M3 reflection (S M3 and I M3) primarily arise from the average axial distance and general ordering of consecutive myosin heads along the thick filament, respectively. Hence, increased spacing and less intensity of the M3 are interpreted as a disordering of the normally ordered OFF state of myosin heads (Huxley & Brown, 1967). Accordingly, in response to piperine, the S M3 increased (S M3: 14.390 ± 0.034 vs. 14.419 ± 0.043 nm, P = 0.029) (Fig. 3B ), whereas the I M3 was unaffected (I M3: 590 ± 166 vs. 518 ± 180 a.u., P = 0.134) (Fig. 3C ). The spacing of the meridional M6 reflection (S M6) primarily arises from the axial distance between the repeats of folded‐back myosin heads, with minor contributions from other structures within the thick filament (Koubassova et al., 2025). In line with the effect of piperine on the S M3, the S M6 also increased in response to piperine (7.229 ± 0.009 vs. 7.238 ± 0.009 nm, P = 0.004) (Fig. 3D ), indicative of myosin heads leaving their highly ordered position on the thick filament and potentially a strain of the thick filament backbone. Finally, the inter‐thick‐filament lattice spacing (d 1,0) relates to the compression of the sarcomere and was unaffected by piperine (39.737 ± 2.340 vs. 39.584 ± 1.764 nm, P = 0.686) (Fig. 3E ). In summary, MyoXRD data suggest that piperine disrupts the axial organisation of consecutive myosin heads as well as inducing a movement of mass from the thick filaments towards the thin filaments in fast‐twitch EDL fibres (Fig. 3F ). Effects of piperine on resting thick filament structure in bundles of fast (extensor digitorum longus, EDL) rat skeletal fibres Values are shown from individual bundles from testing at baseline (black squares) and after 20 min exposure to piperine (blue circles). Repeated measurements from the same bundle are shown by connecting lines, and the model‐based mean ± observed SD are shown as red lines with error bars. The following outcomes are shown: the equatorial intensity ratio (I 1,1/I 1,0) (A), the spacing and intensity of the M3 reflection (S M3 and I M3) (B and C), the spacing of the M6 reflection (S M6) (D) and the inter‐thick‐filament lattice spacing (d 1,0) (E). Finally, we present a schematic illustrating the interpretation of the piperine‐induced changes in sarcomeric structure (F). P values show paired comparisons of baseline and piperine values from 4–13 bundles using linear mixed‐effects models. The illustration in (F) is made using bioRender.com. Slow‐twitch fibres The slow‐twitch soleus fibres showed similar but more consistent effects of piperine on resting thick‐filament structure. In response to piperine, the I 1,1/I 1,0 showed a marked increase (0.53 ± 0.26 vs. 1.10 ± 0.85, P < 0.001) (Fig. 4A ), indicating a movement of mass from the thick filaments towards the thin filaments. Furthermore, piperine increased the S M3 (14.400 ± 0.028 vs. 14.427 ± 0.031 nm, P = 0.005) (Fig. 4B ) and decreased the I M3 (486 ± 102 vs. 399 ± 141 a.u., P = 0.008) (Fig. 4C ), indicating recruitment of myosin heads from their ordered position on the thick filament backbone. Accordingly, the S M6 also increased (7.234 ± 0.009 vs. 7.242 ± 0.008 nm, P = 0.046) (Fig. 4D ). Once again, the d 1,0 was unaffected by piperine (39.447 ± 2.148 vs. 40.246 ± 1.914 nm, P = 0.132) (Fig. 4E ), suggesting no effects on lattice spacing. Hence, our data consistently showed a strong piperine‐induced disruption of the axial organisation of consecutive myosin heads and a piperine‐induced movement of mass from the thick filaments (most probably the myosin heads) towards the thin filaments in slow‐twitch soleus fibres (Fig. 4F ). In summary, we interpret this piperine‐induced state of myosin in both fibre types as a disordered OFF state, which we propose results in increased availability of myosin heads for actin‐binding upon muscle excitation. Effects of piperine on resting thick filament structure in bundles of slow (soleus) rat skeletal fibres Values are shown from individual bundles from testing at baseline (black squares) and after 20 min exposure to piperine (blue circles). Repeated measurements from the same bundle are shown by connecting lines, and the model‐based mean ± observed SD are shown as red lines with error bars. The following outcomes are shown: the equatorial intensity ratio (I 1,1/I 1,0) (A), the spacing and intensity of the M3 reflection (S M3 and I M3) (B and C), the spacing of the M6 reflection (S M6) (D) and the inter‐thick‐filament lattice spacing (d 1,0) (E). Finally, we present a schematic illustrating the interpretation of the piperine‐induced changes in sarcomeric structure (F). P values show paired comparisons of baseline and piperine values from 6–11 bundles using linear mixed‐effects models. The illustration in (F) is made using bioRender.com. Whole‐muscle isometric contractile experiments demonstrate contraction‐type‐dependent effects of piperine From prior literature (Herskind et al., 2024), we expected that isometric contractility would be enhanced by piperine, which we explored in isolated whole muscles during the first 60 min of incubation (Tables 1 and 2; the full dataset is shown in the Appendix, Tables A2 and A3). We report differences between muscles treated with piperine and vehicle, expressed relative to the baseline level. Table 1Effects of piperine on isometric twitch, unfused, and fused tetanic force and force kineticsMuscleTime (min)Frequency (Hz)Peak force (mN)RFD (N s−1)Relaxation t 1/2 (ms)VehiclePiperine P valueVehiclePiperine P valueVehiclePiperine P valueEDL 0 60 2 50 150 2 50 150 111 ± 17 395 ± 72 902 ± 153 108 ± 18 387 ± 75 868 ± 149 104 ± 18 363 ± 70 908 ± 90 137 ± 18 * 492 ± 75 * 856 ± 101 – – – <0.001 <0.001 0.134 6.58 ± 1.1 6.75 ± 1.1 24.97 ± 4.7 6.47 ± 1.1 6.65 ± 1.1 24.08 ± 4.5 6.10 ± 1.1 6.40 ± 1.0 22.54 ± 2.1 8.02 ± 1.0 * 8.48 ± 1.1 * 23.04 ± 2.1 * – – – <0.001 <0.001 <0.001 14.92 ± 0.50 32.25 ± 0.52 39.33 ± 1.54 14.50 ± 0.32 32.17 ± 0.52 40.67 ± 1.17 14.50 ± 0.35 31.20 ± 0.91 38.60 ± 1.85 14.50 ± 0.35 32.80 ± 0.91 * 42.70 ± 1.79 – – – 0.414 <0.001 <0.001 Soleus 0 60 2 20 80 2 20 80 49 ± 14 257 ± 84 463 ± 87 45 ± 14 248 ± 82 459 ± 90 54 ± 14 305 ± 57 529 ± 93 72 ± 19 * 357 ± 59 * 531 ± 100 – – – <0.001 <0.001 0.548 1.91 ± 0.4 1.94 ± 0.4 4.13 ± 0.9 1.80 ± 0.5 1.82 ± 0.4 4.15 ± 1.0 2.10 ± 0.6 2.13 ± 0.6 4.87 ± 0.9 2.64 ± 0.8 * 2.76 ± 0.7 * 5.65 ± 1.0 * – – – <0.001 <0.001 <0.001 35.42 ± 5.01 111.83 ± 10.77 105.33 ± 6.33 33.92 ± 4.22 110.50 ± 10.38 106.25 ± 6.46 37.08 ± 3.63 116.75 ± 7.39 106.67 ± 2.32 40.25 ± 4.10 * 107.83 ± 3.17# 107.08 ± 2.13 – – – <0.001 <0.001 >0.999 Note: The table shows twitch (2 Hz), unfused (50 and 20 Hz) and fused (150 and 80 Hz) tetanic force production, peak rate of force development (RFD) and force relaxation halftime (relaxation t 1/2) from extensor digitorum longus (EDL) and soleus muscles before and after the first 1 h incubation. Contralateral muscles were exposed to two distinct incubation sequences (Fig. 1B), exposing muscles to vehicle or piperine (50 µm). Values in bold with an asterisk (*) and hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than vehicle at the given time point (P ≤ 0.05). This was analysed using mixed effects models to assess the effects of treatment, time point and the interaction between treatment and time point; EDL, n = 6 muscles exposed to vehicle and n = 5 exposed to piperine; Soleus, n = 6 muscles per treatment. Values are presented as the mean ± SD. Effects of piperine on isometric twitch, unfused, and fused tetanic force and force kinetics 0 60 2 50 150 2 50 150 111 ± 17 395 ± 72 902 ± 153 108 ± 18 387 ± 75 868 ± 149 104 ± 18 363 ± 70 908 ± 90 137 ± 18 * 492 ± 75 * 856 ± 101 – – – <0.001 <0.001 0.134 6.58 ± 1.1 6.75 ± 1.1 24.97 ± 4.7 6.47 ± 1.1 6.65 ± 1.1 24.08 ± 4.5 6.10 ± 1.1 6.40 ± 1.0 22.54 ± 2.1 8.02 ± 1.0 * 8.48 ± 1.1 * 23.04 ± 2.1 * – – – <0.001 <0.001 <0.001 14.92 ± 0.50 32.25 ± 0.52 39.33 ± 1.54 14.50 ± 0.32 32.17 ± 0.52 40.67 ± 1.17 14.50 ± 0.35 31.20 ± 0.91 38.60 ± 1.85 14.50 ± 0.35 32.80 ± 0.91 * 42.70 ± 1.79 – – – 0.414 <0.001 <0.001 0 60 2 20 80 2 20 80 49 ± 14 257 ± 84 463 ± 87 45 ± 14 248 ± 82 459 ± 90 54 ± 14 305 ± 57 529 ± 93 72 ± 19 * 357 ± 59 * 531 ± 100 – – – <0.001 <0.001 0.548 1.91 ± 0.4 1.94 ± 0.4 4.13 ± 0.9 1.80 ± 0.5 1.82 ± 0.4 4.15 ± 1.0 2.10 ± 0.6 2.13 ± 0.6 4.87 ± 0.9 2.64 ± 0.8 * 2.76 ± 0.7 * 5.65 ± 1.0 * – – – <0.001 <0.001 <0.001 35.42 ± 5.01 111.83 ± 10.77 105.33 ± 6.33 33.92 ± 4.22 110.50 ± 10.38 106.25 ± 6.46 37.08 ± 3.63 116.75 ± 7.39 106.67 ± 2.32 40.25 ± 4.10 * 107.83 ± 3.17# 107.08 ± 2.13 – – – <0.001 <0.001 >0.999 Note: The table shows twitch (2 Hz), unfused (50 and 20 Hz) and fused (150 and 80 Hz) tetanic force production, peak rate of force development (RFD) and force relaxation halftime (relaxation t 1/2) from extensor digitorum longus (EDL) and soleus muscles before and after the first 1 h incubation. Contralateral muscles were exposed to two distinct incubation sequences (Fig. 1B), exposing muscles to vehicle or piperine (50 µm). Values in bold with an asterisk (*) and hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than vehicle at the given time point (P ≤ 0.05). This was analysed using mixed effects models to assess the effects of treatment, time point and the interaction between treatment and time point; EDL, n = 6 muscles exposed to vehicle and n = 5 exposed to piperine; Soleus, n = 6 muscles per treatment. Values are presented as the mean ± SD. Table 2Effects of piperine on isometric and chaotic relaxation after isometric fused tetaniMuscle/frequency (Hz)Time (min)Inflection point (ms after last stimuli)Rate of isometric relaxation (s−1)Rate of chaotic relaxation (s−1)VehiclePiperine P valueVehiclePiperine P valueVehiclePiperine P valueEDL (150 Hz) 0 20 40 60 24.67 ± 1.37 25.17 ± 1.17 25.67 ± 1.17 25.75 ± 1.04 24.40 ± 1.52 25.70 ± 1.53 26.90 ± 1.56 * 27.90 ± 1.67 * – 0.053 <0.001 <0.001 2.98 ± 0.39 2.94 ± 0.39 2.95 ± 0.36 2.90 ± 0.35 2.90 ± 0.24 2.78 ± 0.29 2.68 ± 0.31# 2.58 ± 0.29# – 0.335 0.016 0.001 61.15 ± 1.28 60.67 ± 1.53 60.64 ± 2.31 60.16 ± 2.19 63.59 ± 2.10 62.18 ± 2.55 61.59 ± 2.13# 61.16 ± 1.76 – 0.707 0.030 0.115 Soleus (80 Hz) 0 20 40 60 73.08 ± 4.76 73.67 ± 5.61 74.00 ± 5.59 74.17 ± 4.81 75.25 ± 3.73 74.00 ± 3.54 75.00 ± 2.76 76.17 ± 3.43 – 0.126 >0.999 >0.999 1.48 ± 0.14 1.45 ± 0.11 1.47 ± 0.11 1.49 ± 0.12 1.50 ± 0.08 1.46 ± 0.08 1.44 ± 0.07 1.42 ± 0.06# – >0.999 0.406 <0.001 24.08 ± 2.64 23.87 ± 2.60 24.04 ± 2.61 24.28 ± 2.92 24.00 ± 2.38 25.06 ± 2.04* 24.86 ± 1.76* 24.13 ± 1.56 – 0.004 0.044 >0.999 Note: The table shows outcomes related to force relaxation after fused tetani in extensor digitorum longus (EDL) (150 Hz) and soleus muscles (80 Hz) during the first 1 h incubation. The outcomes are: (1) the time point (ms after the last stimuli) at which an inflection point distinguishing the initial slow (isometric) force relaxation from the subsequent fast (chaotic) force relaxation was observed; (2) the rate of force relaxation during isometric relaxation; and (3) the rate of force relaxation during chaotic relaxation. Contralateral muscles were exposed to two distinct incubation sequences (presented in Fig. 1B ), exposing muscles to vehicle or piperine (50 µm). Values in bold with an asterisk (*) and a hash symol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than vehicle at the given time point (P ≤ 0.05). Data were analysed using mixed effects models to assess the effects of treatment, time point, and the interaction between treatment and time point; EDL, n = 6 muscles exposed to vehicle and n = 5 exposed to piperine; Soleus, n = 6 muscles per treatment. Values are presented as the mean ± SD. Effects of piperine on isometric and chaotic relaxation after isometric fused tetani 0 20 40 60 24.67 ± 1.37 25.17 ± 1.17 25.67 ± 1.17 25.75 ± 1.04 24.40 ± 1.52 25.70 ± 1.53 26.90 ± 1.56 * 27.90 ± 1.67 * – 0.053 <0.001 <0.001 2.98 ± 0.39 2.94 ± 0.39 2.95 ± 0.36 2.90 ± 0.35 2.90 ± 0.24 2.78 ± 0.29 2.68 ± 0.31# 2.58 ± 0.29# – 0.335 0.016 0.001 61.15 ± 1.28 60.67 ± 1.53 60.64 ± 2.31 60.16 ± 2.19 63.59 ± 2.10 62.18 ± 2.55 61.59 ± 2.13# 61.16 ± 1.76 – 0.707 0.030 0.115 0 20 40 60 73.08 ± 4.76 73.67 ± 5.61 74.00 ± 5.59 74.17 ± 4.81 75.25 ± 3.73 74.00 ± 3.54 75.00 ± 2.76 76.17 ± 3.43 – 0.126 >0.999 >0.999 1.48 ± 0.14 1.45 ± 0.11 1.47 ± 0.11 1.49 ± 0.12 1.50 ± 0.08 1.46 ± 0.08 1.44 ± 0.07 1.42 ± 0.06# – >0.999 0.406 <0.001 24.08 ± 2.64 23.87 ± 2.60 24.04 ± 2.61 24.28 ± 2.92 24.00 ± 2.38 25.06 ± 2.04* 24.86 ± 1.76* 24.13 ± 1.56 – 0.004 0.044 >0.999 Note: The table shows outcomes related to force relaxation after fused tetani in extensor digitorum longus (EDL) (150 Hz) and soleus muscles (80 Hz) during the first 1 h incubation. The outcomes are: (1) the time point (ms after the last stimuli) at which an inflection point distinguishing the initial slow (isometric) force relaxation from the subsequent fast (chaotic) force relaxation was observed; (2) the rate of force relaxation during isometric relaxation; and (3) the rate of force relaxation during chaotic relaxation. Contralateral muscles were exposed to two distinct incubation sequences (presented in Fig. 1B ), exposing muscles to vehicle or piperine (50 µm). Values in bold with an asterisk (*) and a hash symol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than vehicle at the given time point (P ≤ 0.05). Data were analysed using mixed effects models to assess the effects of treatment, time point, and the interaction between treatment and time point; EDL, n = 6 muscles exposed to vehicle and n = 5 exposed to piperine; Soleus, n = 6 muscles per treatment. Values are presented as the mean ± SD. Fast‐twitch muscles In EDL muscles, piperine increased twitch (Fig. 5A ) and unfused tetanic forces (Fig. 5B ) (both treatment × time point: P < 0.001), whereas fused tetanic force was not affected (Fig. 5C and Table 1) (treatment × time point: P = 0.201). After 60 min of incubation, piperine increased twitch and unfused tetanic force by a mean (95% confidence interval) of 36% (29–43%) (P < 0.001) and 38% (31–46%) (P < 0.001), respectively. At the same time, the maximal RFD of the twitch, unfused, and fused tetanic contractions (all treatment × time point: P < 0.001) increased by 34% (28–41%) (P < 0.001), 35% (27–43%) (P < 0.001) and 2.0% (1.1–2.8%) (P < 0.001), respectively. Subsequently, 60 min of piperine treatment did not significantly affect the relaxation halftime (t 1/2) of the twitch [2.7% (−1.2% to 6.5%), P = 0.414] compared to vehicle (see Appendix, Table A2). By contrast, piperine increased the relaxation t 1/2 of unfused contractions by 5.7% (3.3–8.2%) (P < 0.001) after 60 min compared to vehicle. Similarly, the fused contractions showed prolonged relaxation t 1/2 [7.0% (3.9–10.1%), P < 0.001] compared to vehicle. Relaxation after fused tetanic contractions proceeds in a biphasic manner with an initial slow (linear) phase and a subsequent fast (exponential) phase. These phases are generally referred to as isometric and chaotic relaxation, respectively, as a result of the sarcomere behaviour during these phases (Brunello et al., 2009; Hill et al., 2021, 2025, 2026; Poggesi et al., 2005). In the fast EDL muscles, we observed a piperine‐induced increase in the duration of the isometric relaxation phase of 9.8% (6.4–13.2%) (P < 0.001) compared to vehicle (Table 2). This change manifested as a right shift of the inflection point between the slow and fast relaxation phases, as shown in Fig. 5C . Accordingly, 60 min of piperine incubation decreased the rate of relaxation during the initial isometric phase by 8.2% (2.7–13.8%) (P = 0.001) compared to vehicle (Table 2). Finally, the rate of relaxation during the subsequent fast chaotic phase was slightly decreased after 40 min of piperine incubation [−2.5% (−4.8% to −0.2%), P = 0.030] compared to vehicle (Table 2). However, no significant change was detected after 60 min of piperine incubation [−2.0% (−4.3% to 0.3%), P = 0.115] (Table 2). Finally, in the second incubation phase (Fig. 1B ), the effects of piperine were found to be both reversible and reproducible (see Appendix, Table A2). Effects of piperine on isometric contractility of intact fast (extensor digitorum longus, EDL) rat skeletal muscles Exemplary force traces are shown from EDL muscles exposed to vehicle and piperine at the start (0 min) and end (60 min) of the first incubation. Force traces (n = 1 muscle per treatment) from twitch (2 Hz) (A), unfused tetanic (50 Hz) (B) and fused tetanic (150 Hz) (C) contractions are shown. For each contraction, the full force trace is shown together with inserts highlighting the phases of force development and relaxation. Force relaxation in (C) is illustrated starting from the time point of the final stimuli and shows the inflection points (group averages) distinguishing the slow (isometric) and fast (chaotic) phases of force relaxation after fused tetani. Slow‐twitch muscles Similar to the EDL muscles, the twitch (Fig. 6A ) and unfused tetanic forces of the soleus muscles (Fig. 6B ) (both treatment × time point: P < 0.001) increased in response to piperine, whereas the fused tetanic force was unaffected (treatment × time point: P = 0.303) (Fig. 6C ). In the soleus, piperine increased twitch and unfused force by 43% (37–49%) (P < 0.001) and 21% (16–27%) (P < 0.001), respectively. Twitch and unfused tetanic RFD (both treatment × time point: P < 0.001) of the soleus muscles increased by 32% (27–37%) (P < 0.001) and 37% (31–42%) (P < 0.001), respectively. Notably, RFD of fused tetanic contractions (treatment × time point: P < 0.001) in soleus muscles increased substantially by 16% (13–19%) (P < 0.001). After 60 min of incubation, piperine increased the twitch relaxation t 1/2 of the soleus by 12.7% (6.3–19.1%) (P < 0.001) (Table 1) compared to vehicle. By contrast, piperine decreased the relaxation t 1/2 of unfused contractions by 6.2% (3.3–9.0%) (P < 0.001) after 60 min, while the fused contractions showed no change in relaxation t 1/2 at 60 min [−0.7% (−2.7% to 1.3%), P > 0.999]. In the slow soleus muscles, we observed no effect of piperine on the length of the isometric relaxation phase, as the inflection time point was unchanged [−0.3% (−3% to 2.3%), P > 0.999] (Fig. 6C and Table 2). In terms of the rates of isometric and chaotic relaxation, we observed less consistent changes in response to piperine compared to the changes observed in the fast muscle (Table 2). Piperine decreased the rate of isometric relaxation after 60 min compared to vehicle [6.0% (1.9% to 10.1%), P = 0.001]. By contrast, the rate of chaotic relaxation was increased at 20 min (P = 0.004) and 40 min (P = 0.044) but unchanged at 60 min [0.3% (4.4% to −3.8), P > 0.999]. Finally, in the second incubation phase (Fig. 1B ), we again found that the effects of piperine were both reversible and reproducible (soleus; see Appendix, Table A3). Effects of piperine on isometric muscle function of intact slow (soleus) rat skeletal muscles Exemplary force traces are shown from soleus muscles exposed to vehicle and piperine at the start (0 min) and end (60 min) of the first incubation. Force traces (n = 1 muscle per treatment) from twitch (2 Hz) (A), unfused tetanic (20 Hz) (B) and fused tetanic (80 Hz) (C) contractions are shown. For each contraction, the full force trace is shown together with inserts highlighting the phases of force development and relaxation. Force relaxation in (C) is illustrated starting from the time point of the final stimuli and shows the inflection points (group averages) distinguishing the slow (isometric) and fast (chaotic) phases of force relaxation after fused tetani. Piperine‐induced disruption of the ordered OFF state of myosin enhances low‐ and high‐frequency dynamic contractility, with more pronounced effects in slow muscle Muscles working in vivo will often experience activation frequencies leading to subtetanic contraction (Gorassini et al., 2000; Pucci et al., 2006); therefore, a comprehensive assessment of muscle function must also include testing at submaximal activation frequencies. Also, muscle contractions are usually dynamic in vivo, and the contractile power is governed by the relationship between contractile force and shortening velocity. Accordingly, force–velocity curves were determined using muscle‐type‐specific low‐ and high‐frequency stimulation protocols. Below, we show exemplary force–velocity contractions (Fig. 7A ) along with EDL and soleus force–velocity curves and power curves from baseline (FV1) testing (Fig. 7B and C ). We report differences between muscles treated with piperine and vehicle (FV2) expressed relative to baseline (FV1) (see Appendix, Table A4). Absolute values from force–velocity testing are shown in the Appendix (Tables A5 and A6). Assessment of low‐ and high‐frequency dynamic contractility by force–velocity testing A, exemplary low‐frequency (purple) and high‐frequency (black) contractions (n = 1 extensor digitorum longus (EDL) muscle) at relative loads of 5%, 40% and 100% of maximal low‐ and high‐frequency isometric force (F max) with corresponding displacements of the lever arm. Measured steady forces and shortening velocities were used to construct force–velocity (FV) and power curves. B and C, baseline (FV1) low‐frequency (purple squares) and high‐frequency (black circles) EDL and soleus FV (filled symbols, solid lines) and power (open symbols, dotted lines) curves, respectively. Points on the FV (left y‐axis) and power curves (right y‐axis) are shown as mean values with vertical error bars showing SD on the y‐axis. Horizontal error bars show the SD of the measured force as a percentage of the maximal isometric force (F max). Corresponding Hill curves are shown as mean lines; n = 6 EDL and 6 soleus muscles. Low‐frequency activation Piperine induced marked and highly consistent increases in low‐frequency dynamic contractility in both muscle types (see Appendix, Tables A5 and A7). For the contractile power of the EDL muscles, we found significant main effects of both treatment (P < 0.001) and relative load (P < 0.001), as well as the interaction between treatment and relative load (P < 0.001) (Fig. 8A ). Piperine increased contractile power across all the relative loads below isometric F max, within a range of 26–121% (all P ≤ 0.021) compared to vehicle (Fig. 8A ). Also, low‐frequency isometric force increased by 25% (14–35%) (P = 0.003) (Fig. 8A ). These changes in the EDL muscles manifested as piperine‐induced increases in low‐frequency V max and P max by 25% (16–34%) (P = 0.002) and 35% (22–48%) (P = 0.002), respectively (Fig. 8B and C ). Also, the curvature of the force–velocity curve increased as a/F o decreased by 36% (25–47%) (P < 0.001) (Fig. 8B and C ). For power in the soleus, we also found significant main effects of both treatment (P < 0.001) and load (P < 0.001), as well as an interaction between treatment and load (P < 0.001) (Fig. 8D ). Again, piperine increased the contractile power across all the relative loads below isometric F max, within a range of 35–116% (all P ≤ 0.003) compared to vehicle (Fig. 8D ). Also, low‐frequency isometric force increased by 27% (20–33%) (P < 0.001) (Fig. 8D ). These changes in the soleus muscles, similarly to those in the EDL, led to piperine‐induced increases in low‐frequency V max and P max of 20% (10–30%) (P = 0.005) and 54% (44–64%) (P < 0.001), respectively, however, with no effect on curvature of the force–velocity relationship (P = 0.450) (Fig. 8E and F ). Effects of piperine on low‐frequency dynamic contractility of fast (extensor digitorum longus, EDL) and slow (soleus) rat skeletal muscles Top: curves show absolute low‐frequency EDL (60 Hz) (A) and soleus (20 Hz) (D) force–velocity (FV) curves (filled symbols, solid lines) and power curves (open symbols, dotted lines) after contralateral piperine (blue squares) and vehicle (orange circles) treatments. Curves show group means as absolute values. Individual points on the FV curves (left y‐axis) and power curves (right y‐axis) are shown as absolute mean values with vertical error bars showing SD on the respective y‐axis. Horizontal error bars show the SD of the measured absolute force for each contraction. The boxes show P values from statistical analyses of the main effects of treatment (piperine and vehicle), load (5%, 15%, 27.5%, 40%, 60%, 80% and 100% of initial F max) and their interaction (treatment × load) by two‐way ANOVAs (soleus) and mixed‐effects models (EDL). An asterisk (*) and hash symbol (#) with the associated P value denotes a significant post hoc test showing a difference in contractile power and isometric force (paired t test), respectively, between treatments at the given relative load when normalised to baseline (FV1). Mean r 2 ± SD of absolute Hill fits in the figure: EDL piperine: 0.992 ± 0.005, EDL vehicle: 0.994 ± 0.002, soleus piperine: 0.997 ± 0.002, soleus vehicle: 0.992 ± 0.006. Curves in the centre panel show FV and power curves for EDL (B) and soleus (E) muscles as baseline‐normalised (FV1) group means, with shades indicating SD. Bars in the bottom panel (C and F) show corresponding baseline‐normalised Hill‐equation estimates of maximal unloaded shortening velocity (V max), a/F o (which is inversely related to the FV curvature), and maximal power output (P max) as the mean ± SD based on paired data points. Circles and connecting lines represent the values of individual muscles and their contralateral pairings, respectively. P values over the bars are from paired t tests comparing changes from baseline for piperine and vehicle (n = 5 EDL and 6 soleus pairs). High‐frequency activation Interestingly, piperine also showed effects on the high‐frequency force–velocity curves in both muscle types (see Appendix, Tables A6 and A7). For power in the EDL, we found a significant main effect of relative load (P < 0.001), with no main effect of treatment (P = 0.560) and no significant interaction between treatment and relative load (P = 0.397) (Fig. 9A ). Nonetheless, piperine elevated contractile power at the lowest load (5% of initial F max) by 3.1% (0.5–5.7%) (P = 0.028) compared to vehicle (Fig. 9A ). Furthermore, high‐frequency isometric force was unchanged (P = 0.319) (Fig. 9A ). As a result, V max increased by 5% (3–7%) (P = 0.003), whereas curvature increased as a/F o decreased by 13% (0.4–26%) (P = 0.045). As a result of the decreased curvature, P max decreased slightly by 2.4% (0.1–4.6%) (P = 0.042) (Fig. 9B and C ). By contrast, the soleus muscles exclusively showed positive effects in response to piperine at high‐frequency stimulation. We found significant main effects of both treatment (P = 0.004) and relative load (P < 0.001), yet no interaction (P = 0.210) (Fig. 9D ). Piperine elevated power at the three lowest relative loads (5%, 15% and 27.5% of initial F max) compared to vehicle by 8.8% (3.1–14.6%) (P = 0.007), 11.8% (6.4–17.2%) (P = 0.001) and 10.3% (2.5–18.2%) (P = 0.016), respectively. Also, high‐frequency isometric force was unchanged (P = 0.751) (Fig. 9D ). These effects manifested as a piperine‐induced increase in V max and P max of 9% (5–13%) (P = 0.002) and 11% (6–15%) (P = 0.002), respectively, with no change in curvature (P = 0.162) (Fig. 9E and F ). Finally, in an additional force–velocity test (FV3) (Fig. 1B ), the effects of piperine on dynamic muscle function were shown to be both reversible and reproducible in both muscle types (see Appendix, Tables A5, A6, and A7). Effects of piperine on high‐frequency dynamic contractility of fast (extensor digitorum longus, EDL) and slow (soleus) rat skeletal muscles Top: curves show absolute high‐frequency EDL (150 Hz) (A) and soleus (80 Hz) (D) force–velocity (FV) curves (filled symbols, solid lines) and power curves (open symbols, dotted lines) after contralateral piperine (blue squares) and vehicle (orange circles) treatments. Curves show group means as absolute values. Individual points on the FV curves (left y‐axis) and power curves (right y‐axis) are shown as absolute mean values with vertical error bars showing SD on the respective y‐axis. Horizontal error bars show the SD of the measured absolute force for each contraction. The boxes show P values from statistical analyses of the main effects of treatment (piperine and vehicle), load (5%, 15%, 27.5%, 40%, 60%, 80% and 100% of initial F max) and their interaction (treatment × load) by two‐way ANOVAs (soleus) and mixed‐effects models (EDL). An asterisk (*) with the associated P value denotes a significant post hoc test showing a difference in contractile power between treatments at the given relative load when normalised to baseline (FV1). Mean r 2 ± SD of absolute Hill fits for both EDL and soleus muscles exposed to both treatments: 0.999 ± 0.001. Curves in the centre panel show FV and power curves for EDL (B) and soleus (E) muscles as baseline‐normalised (FV1) group means, with shades indicating SD. Bars in the bottom panel (C and F) show corresponding baseline‐normalised Hill‐equation estimates of maximal unloaded shortening velocity (V max), a/F o (which is inversely related to the FV curvature) and maximal power output (P max) as the mean ± SD based on paired data points. Circles and connecting lines represent the values of individual muscles and their contralateral pairings, respectively. P values over the bars are from paired t tests comparing changes from baseline for piperine and vehicle (n = 5 EDL and 6 soleus pairs). Discussion We show here, for the first time, that piperine disrupts the ordered OFF state of myosin in the thick filament in resting fast and slow skeletal muscle, favouring a disordered (primed) OFF state of myosin. Furthermore, we reveal that this piperine‐induced disruption leads to substantial enhancement of contractile power in both muscle types when stimulated to contract by low‐frequency electrical stimulation; however, contractile power was enhanced almost exclusively in slow muscle during high‐frequency stimulation. Piperine disrupts the ordered OFF state of myosin in resting skeletal muscle of both fibre types The positioning of myosin heads relative to the thick filament determines their availability for actin interaction upon Ca2 +‐mediated thin‐filament activation (Brunello & Fusi, 2024). Hence, to test whether the previously observed potentiation of contractile force induced by piperine in both fibre types of skeletal muscle (Herskind et al., 2024) could be caused by structural shifts priming the thick filament, we applied MyoXRD on bundles of resting permeabilised muscle fibres. Taken together, our MyoXRD data show that piperine does indeed disrupt the ordered OFF state of myosin and thereby favours a primed OFF state in both fibre types. There was consistent directionality across all outcomes, pointing to a disruption of the axial ordering of myosin heads as well as a mass movement from the thick filament towards the thin filament in both soleus and EDL bundles. Based on prior mechanistic findings, these effects are probably mediated by piperine binding to RLC (Tolkatchev et al., 2018). Complicating MyoXRD interpretations, the regulatory protein myosin‐binding protein C (MyBP‐C) has recently been shown to make a significant contribution to the M3 reflection (Koubassova et al., 2025). This is caused by the third order of the ∼43 nm MyBP‐C periodicity, which overlays the ∼14.35 nm first‐order crown repeat, possibly hiding or exaggerating changes in myosin‐head ordering on the thick filament backbone. MyBP‐C can exist in several conformations, and this can affect the reflections in ways not yet defined, but work using the new ‘cut‐and‐paste’ MyBP‐C mouse model holds promise to answer these questions soon (Engels et al., 2026). Although alterations in thick filament structure during contraction have been subject to numerous studies in recent years (Brunello et al., 2023; Caremani et al., 2019; Caremani et al., 2023; Gong et al., 2022; Hill et al., 2021, 2022, 2026; Linari et al., 2015; Reconditi et al., 2011; Zhao et al., 2024), exogenous thick‐filament priming in resting skeletal muscles and its consequences for contractile function have been very sparsely investigated. At present, options for studying exogenous thick‐filament priming in intact skeletal muscles rely on the use of (1) transgenic animals expressing supraphysiological levels of the thick‐filament priming 2‐deoxy‐ATP (dATP) (Ma et al., 2020) or (2) cardiac‐specific thick‐filament primers with poor affinity for especially fast skeletal muscle (Governali et al., 2020; Karimi et al., 2024; Lindqvist et al., 2019; Nagy et al., 2015; Potoskueva et al., 2025; Radke et al., 2014). Another approach is the induction of the physiological potentiation phenomenon, post‐tetanic potentiation (PTP), which potentiates force in fast‐twitch fibres by Ca2 +‐dependent RLC phosphorylation (Vandenboom, 2016). Using time‐resolved MyoXRD on live tarantulas, it has been elegantly shown that PTP is caused by a disruption of the thick filament structure, showing as a prolonged recovery of the ordered OFF state during relaxation, explaining the subsequent force potentiation (Padrón et al., 2020). However, PTP is a very short‐lived force potentiation in fast skeletal muscles, which only disrupts the resting thick filament structure on a timescale of seconds. Thus, these approaches all have limitations in terms of their accessibility, ability to induce thick‐filament priming acutely or ability to induce priming for longer periods of time in skeletal muscle preparations. Piperine has previously been shown to disrupt the thick filament structure in resting cardiomyocytes (Jani et al., 2024). Our data expand on those findings, showing that piperine also induces thick‐filament priming across both fibre types of skeletal muscle. Hence, piperine represents a promising tool for inducing thick‐filament priming in skeletal muscle, offering advantages over currently limited options such as PTP, dATP or cardiac‐specific primers. However, we emphasise that the required dose of piperine to affect the contractile machinery is not feasible to achieve in human beings without off‐target safety concerns (Ziegenhagen et al., 2021). Moreover, therapeutic disruption of the ordered OFF state of myosin to increase energy expenditure and contractility would be a tight balancing act between favourable effects and pathological imbalance (Ochala, 2026). Piperine‐induced disruption of the ordered OFF state of myosin enhances dynamic contractility in skeletal muscles, with more pronounced effects in slow muscles Dynamic muscle function is essential for physical functioning and well‐being (Freitas et al., 2024), making it a highly important outcome to assess when investigating modulation of the contractile machinery. Furthermore, using fast and slow muscle types and stimulation patterns with both tetanic and subtetanic frequencies allows for evaluations that are probably more translatable to muscle work in vivo. Therefore, we investigated the effects on dynamic muscle function in fast and slow skeletal muscles by determining force–velocity curves from high‐ and low‐frequency stimulation. Here, we found that piperine drastically enhanced power in a large range of relative loads (5–80% of initial low‐frequency F max) (Fig. 8A and D ) in both muscle types. These changes in the relationships between load and shortening velocity led to a marked enhancement of V max and P max during low‐frequency stimulation in both muscle types (Fig. 8C and F ). These findings correlate well with the findings reported by Herskind et al. 2024 showing that piperine potentiates isometric contractions induced by low‐frequency stimulation (Herskind et al., 2024). Skeletal muscles stimulated at low frequencies will have subsaturating intracellular Ca2+ levels, and thereby the contractile machinery will be sensitive to the piperine‐induced modulation of Ca2+‐sensitivity (Herskind et al., 2024). In the present study, the magnitudes of potentiation of low‐frequency P max were substantial (EDL: ∼35% and soleus: ∼54%), indicating great potential of exogenous thick‐filament priming to enhance low‐frequency dynamic contractility, a common type of muscle contraction in vivo (Gorassini et al., 2000). Unexpectedly, we also found that piperine modified dynamic muscle function even during high‐frequency electrical stimulation. Piperine enhanced contractile power at a relative load of 5% of the initial high‐frequency F max (Fig. 9A ) in EDL muscles, at the same time as showing substantial effects in the soleus muscles by enhancing power at relative loads of 5%, 15% and 27.5% (Fig. 9D ). However, only in the soleus muscles did we observe a statistically significant main effect of treatment (piperine vs. vehicle) for contractile power, suggesting that piperine enhances power production of the overall high‐frequency force–velocity relationship exclusively in the slow soleus muscles. Previous studies have shown that (1) a resting pool of constitutively primed myosin motors facilitates low‐load shortening (Linari et al., 2015) and (2) the number of actin‐bound ON myosin motors governs the force–velocity curve (Piazzesi et al., 2007). Here, we show that exogenous priming of resting myosin (1) increases V max at high‐frequency stimulation (EDL: ∼5% and soleus: ∼9%) (Fig. 9C and F ) and (2) modulates the force–velocity curves of both muscle types towards higher power outputs at low loads (Fig. 9A and D ) during high‐frequency stimulation. By contrast to our findings, it has previously been reported that piperine does not affect the shortening velocity at 25% of maximal isometric force in maximally Ca2+‐activated fast‐twitch single fibres (Nogara et al., 2016). These experiments were performed using a temperature‐jump protocol (5–25°C) at the same time as testing shortening velocity at only one relative load (25% of isometric max). Hence, discrepancies between our findings and the previous study may be explained by a more comprehensive assessment of dynamic contractility performed in our study, along with differences in the experimental temperatures and preparations. Taken together, piperine appears able to modulate the underlying physiological determinants of dynamic muscle function, leading to substantial enhancement in dynamic contractility. Based on our findings of the thick‐filament priming induced by piperine, our contractile experiments can be viewed in a broader perspective. Hence, in the present study, we show that exogenous thick‐filament disruption of skeletal muscles potentiates dynamic muscle function of fast and slow muscles during low‐frequency stimulation. Unexpectedly, the potential of piperine to enhance dynamic contractility during high‐frequency stimulation was more pronounced in the slow muscles compared to the fast muscles because P max increased exclusively in the slow soleus muscles (∼11%). Indeed, high‐frequency P max of the fast EDL muscles decreased slightly (∼2%), despite the above‐mentioned enhanced ability to produce higher power at low load (5% of initial F max). Thus, our data indicate muscle‐type‐specific differences in the level of enhancement of dynamic muscle function by exogenous thick‐filament disruption. These differences may be explained by recent findings showing that the kinetics of thick‐filament disruption during contraction are muscle‐type‐dependent (Gong et al., 2022; Hill et al., 2022; Zhao et al., 2024). Very recently, Hill et al. (2026) suggested that not only the kinetics, but also the overall levels of thick‐filament disruption during contraction are muscle type‐dependent. Hill et al. (2026) proposed that, in tetanically stimulated slow rat soleus muscle, as little as ∼10% of myosin motors actively bind to actin, with ∼70% of myosin motors staying in the ordered OFF state. This is in stark contrast to tetanically stimulated fast mouse EDL muscle, where ∼25% of myosin motors actively bind to actin, with only ∼30% of myosin motors staying in the ordered OFF state (Hill et al., 2021, 2022, 2025). In this perspective, we speculate that the large effects on dynamic muscle function in the slow soleus muscle observed in the present study could indicate that piperine (1) recruits otherwise constitutively ordered OFF myosin motors in soleus muscles and/or (2) promotes actin‐binding of the non‐actin‐bound myosin motors that are already in the disordered (primed) OFF state. Importantly, we observed no effects of piperine on high‐frequency maximal isometric force production. Hence, this suggests that none of the above‐presented hypotheses can enhance high‐frequency isometric force in either of the muscle types. Taken together, prior evidence suggests that a pool of constitutively ordered OFF myosin motors represents a substantial fraction of the overall myosin population in slow muscles, and to a smaller extent in fast muscles. Despite these differences, we show that this apparent contractile reserve capacity cannot be recruited during high‐frequency contractions against high relative loads. However, the effects of piperine on unloaded to medium‐loaded high‐frequency contractions suggest that there is a thick‐filament‐based contractile reserve capacity that can be recruited, although to a much larger degree in slow compared to fast skeletal muscle as we have recently discussed elsewhere (Kruse et al., 2026). Effects of piperine on force development and relaxation kinetics suggest complex muscle‐type‐specific mechanisms We observed apparently muscle‐type‐specific effects of piperine on force development (RFD) (Table 1; see also the Appendix, Tables A2 and A3) and force relaxation (Tables 1 and 2; see also the Appendix, Tables A2 and A3) that reveal the complexity of piperine‐potentiation across muscle types. In EDL muscles, piperine increased RFD of fused tetanic contractions by only ∼2%, whereas it increased by ∼16% in soleus muscles. In notion, Herskind et al. (2024) reported a similar tendency, with piperine inducing numerically larger increases in fused tetanic RFD of soleus muscles compared to EDL. In terms of force relaxation after fused tetani, we unexpectedly found that piperine increased the length of the initial isometric relaxation phase and seemed to reduce the relaxation rates of both the slow isometric and the fast chaotic relaxation phases, specifically in the fast EDL muscle. In notion, these findings of prolonged relaxation in response to myosin disruption by piperine warrant caution in the perspective of using such approaches to treat muscular pathologies, such as myotonic dystrophy, already prolonging muscle relaxation. These divergent findings on RFD and relaxation between muscle types probably reflect distinct contributions of mechanisms involved in force development and relaxation between muscle types. Kinetics of RFD and force relaxation during fused tetanic contractions integrates multiple mechanisms, including: (1) Ca2 +‐dependent thin‐ and thick‐filament activation/deactivation kinetics, (2) strain‐dependent thick‐filament activation/deactivation kinetics and (3) cross‐bridge cycling (Brunello & Fusi, 2024; Caremani et al., 2023; Hill et al., 2022, 2025). The effort to decipher the individual contributions of these intertwined mechanisms is complicated even more by the recently proposed phenomenon of muscle‐type‐specific thick‐filament activation/deactivation kinetics, as discussed in the section above. Finally, we cannot exclude that these differences may be a result of isoform‐dependent interactions of piperine with sarcomeric regulatory proteins, such as RLC, MyBP‐C, and titin. Hence, the cause for these divergent effects of piperine on the kinetics of force development and relaxation may be found in the complex interaction between the affinity of piperine and/or the influence of fibre‐type‐specific regulatory effects of Ca2+, strain, and other sarcomeric proteins. Limitations In MyoXRD experiments, we used bundles of permeabilised resting muscle fibres, a preparation known to experience cell swelling that can lead to some disruption of the resting sarcomere structure (Caremani et al., 2021). Cell swelling can be counteracted by applying a compressor molecule such as dextran (Caremani et al., 2021); however, as a result of the poor solubility of piperine's and the viscosity of dextran, we did not include dextran. Hence, a limitation of the present study relates to the definition of the ordered OFF state of myosin and the regulatory sensitivity of the thick filament. We argue that the permeabilised preparations in the present study produce valuable information on the general effects of piperine on the orientation of the myosin heads. Under our experimental conditions (without dextran/27°C), the thick filament myosin motors are still in a quasi‐stabilised ordered OFF motor conformation (Caremani et al., 2021; Ovejero et al., 2022). In these conditions, we can clearly interpret whether piperine treatment alters the thick filaments, including the directionality of such changes. Exactly how this mechanism is orchestrated will be better determined in future intact‐muscle experiments, where interference measurement of the M3 reflection, as well as myosin layer lines 1 and 4, can be made available, and the thick filament is in a more in vivo‐like state. Subsequently, we accounted for the inherent risk of radiation damage in a pre/post‐design by assessing the amount of beamline exposure which inflicted radiation damage. Radiation damage was found to occur above 300 ms exposure, and we set a limit of 100 ms exposure for any given area in experiments. Furthermore, using similar study designs and muscle preparations, prior studies have shown the ability to perform pre/post measurements using a 20 min incubation without confounding by the incubation phase or radiation damage (Hessel et al., 2022; Hessel, Engels et al., 2024). Finally, we did not determine the fibre types of the fibres used in MyoXRD experiments; however, we utilised rat EDL and soleus muscles, overwhelmingly composed of type II and I fibres, respectively (Cornachione et al., 2011). In our contractile experiments, we did not measure muscle length at L o, which prevents us from expressing shortening magnitudes and shortening velocities relative to L o. Yet, our experiments were performed using very homogeneous muscles from rats standardised by vendor, strain, gender and age, which have previously been shown to result in a consistent muscle length at L o in both soleus and EDL muscles (Jakobsgaard et al., 2021). Furthermore, all contractile experiments were performed by the same researcher (DZK), limiting variability in the dissection of muscles, the tying/placement of sutures on the isolated preparations, and the initial protocol used for finding L o. In the Appendix (see Appendix, Tables A8 and A9), we show low‐ and high‐frequency Hill estimates of F max, V max and P max normalised to physiological cross‐sectional area (PCSA), estimated muscle length at L o, and muscle weight, respectively. PCSA was estimated by the approach described by Jakobsgaard et al. (2021). Muscle lengths at L o for both soleus and EDL muscles are reused from Jakobsgaard et al. (2021), with muscle weight being measured in the present experiments. Force–velocity tests were executed throughout 60 min, making the overall experimental protocol strenuous on the preparations. We handled these issues by determining neighbouring force–velocity points at different points in the sequence to average the small impact of decreases in preparation quality during the force–velocity test (Kristensen et al., 2019). In addition, testing of low‐ and high‐frequency force–velocity points was performed shortly after each other (5 s), yet this did not result in excessive reductions in high‐frequency isometric force production when comparing forces from the start/end of incubations (see Appendix, Tables A2 and A3) with the corresponding maximal forces from the three FV tests (see Appendix, Table A6). Finally, to construct force–velocity curves, we employed isotonic contractions defined as relative values of the absolute low‐ and high‐frequency isometric maximal force at baseline. This means that changes in the contractile apparatus during the protocol manifested as changes in shortening velocity, even though the major underlying causes were probably related to changes in force output and not the isolated ability of the sarcomere to shorten. Future directions We observed marked muscle‐type‐dependent differences in the potential of piperine to enhance dynamic contractility. This may suggest that exogenous thick‐filament priming modifies the physiological load‐dependent kinetics of thick‐filament recruitment and de‐recruitment in a muscle‐type‐dependent manner. Hence, future studies should utilise time‐resolved MyoXRD to understand the nature of the muscle‐type‐dependent effects of exogenous thick‐filament priming on dynamic muscle function. Conclusions To conclude, our data strongly indicate that piperine (1) disrupts the ordered OFF state of myosin in resting skeletal muscle of both fibre types and (2) enhances dynamic muscle function at submaximal stimulation levels in both fast and slow skeletal muscles, whereas it only enhances contractility of the slow muscle type during maximal stimulation. Hence, we propose piperine as a tool for the investigation of exogenous thick‐filament priming in skeletal muscle. Furthermore, we reveal that thick‐filament priming in skeletal muscle leads to muscle‐type‐dependent magnitudes of potentiation of dynamic muscle function. Such effects must be further investigated and must be accounted for in future efforts to leverage the therapeutic potential of skeletal‐muscle thick‐filament priming in the treatment of contractile impairments. Additional information Competing interests ALH and MNK are owners of Accelerated Muscle Biotechnologies (AMB) which consulted on the collection and interpretation of the MyoXRD data; however, services rendered were not linked to outcome. The author team declare that they have no competing interests. Author contributions D.Z.K., K.O. and A.L.H. conceived the experiments. D.Z.K., K.O., J.H., M.N.K., A.J.K. and A.L.H. carried out the experiments. D.Z.K. and A.L.H. analysed data. All authors contributed to the interpretation of the results. D.Z.K. wrote the first draft and later revised the manuscript. All authors helped shape the paper and approved the final version. Funding The study was supported by grants from the Research Pool of the Ministry of Culture in Denmark [SUAKPKfor2W.2024‐022], Aarhus University Research Foundation [AUFF‐E‐2023‐9‐11] and the German Research Foundation [LO 2951/2‐1]. Generative AI statement No generative AI tools were used in the preparation of this manuscript. Translational perspective A fundamental question in muscle physiology concerns whether there is control of the fraction of available myosin heads during maximal muscle contraction. Our work adds nuances to this question by demonstrating that piperine, a naturally occurring alkaloid from black pepper, disrupts the highly ordered resting state of the myosin‐containing thick filament in mammalian skeletal muscle. Remarkably, our results suggest that there is a contractile reserve capacity of myosin motors in slow skeletal muscles, which may be recruited by piperine and similar myosin‐priming compounds. Unexpectedly, this regulation by piperine enhanced the maximal power output of specifically the slow type of skeletal muscle. In a broader perspective, these results highlight the complexity (and possible therapeutic potential) of the regulation of skeletal muscle contraction in response to myosin‐priming compounds like piperine. In this regard, the effects of piperine and similar compounds on the energetic efficiency of muscle contraction need to be investigated. Dependent on future findings, piperine or similar compounds may be used as lead compounds to develop skeletal‐muscle‐specific therapeutics combating disease and age‐induced impairments in contractile and/or metabolic function. Supporting information Peer Review History Supplementary Material Acknowledgements We thank Khoi Nguyen from Accelerated Muscle Biotechnologies (AMB) for his assistance in the MyoXRD experiments. Also, we thank Cuno Rasmussen for his assistance in designing software for the analysis of the contractile data. We acknowledge DESY (Hamburg, Germany), a member of the Helmholtz Association HGF, for the provision of experimental facilities. Parts of this research were carried out at PETRA III. X‐ray diffraction data were collected using the P03 beamline operated/provided by DESY Photon Science. We thank Matthias Schwartzkopf and Jan Rubeck for assistance during the experiments. Beamtime was allocated for proposals I‐20221421 and II‐20241178. Biography Daniel Zornow Kruse is currently pursuing his PhD degree in Muscle Physiology at Aarhus University in Denmark under the supervision of Professor Kristian Overgaard. He obtained a Bachelor's degree in Sport Science in 2022 and a subsequent Master's degree in Human Physiology in 2024. His PhD research aims to investigate the contractile and metabolic consequences of exogenous modulation of the myosin‐containing thick filament in skeletal muscle. This work is performed using whole‐muscle physiological measurements of muscle contractility coupled with subsequent assays investigating metabolism. Furthermore, he employs biophysical experiments to determine the effects of compounds on the structure of sarcomeric proteins. Doc. A1. Effect of sarcomere length (SL) in MyoXRD experiments To validate our MyoXRD results, we used the well‐known length‐dependent disruption of the thick filament (Hessel et al., 2022; Reconditi et al., 2014) to assess the quality of our preparations. A subgroup of EDL bundles was tested at SL 2.4 and 2.7 µm before and after piperine incubation (Table A1). When comparing baseline values from the EDL bundles at SL 2.4 and SL 2.7, we saw an increase in the S M3 (SL 2.4: 14.361 ± 0.068 (model‐based mean ± observed SD) vs. SL 2.7: 14.390 ± 0.034 nm, P = 0.033) as expected when stretching the sarcomere. This suggests an increased axial periodicity of consecutive myosin motors in response to the stretch. Example force‐ and length traces from each low‐ and high‐frequency contraction used to construct force–velocity (FV) curves Data from extensor digitorum longus (EDL) (n = 1) and soleus (n = 1) muscles. To determine the low‐ and high‐frequency force–velocity (FV) curves, each muscle performed electrically induced contractions against varying external loads (5%–100% of low‐ and high‐frequency maximal isometric force). The approach was to determine the FV curve by isotonic contractions using the afterload method. Hence, an isometric force was developed until the desired force was achieved (as a percentage of the baseline‐defined maximal isometric force indicated above each panel), after which the muscle was allowed to shorten against the relative load. Table A1Effects of piperine on resting thick‐filament structure of fast (extensor digitorum longus, EDL) and slow (soleus) rat fibresEDLSoleusSL 2.4 µmSL 2.7 µmSL 2.7 µmPrePost P valuePrePost P value Pre 2.4 vs. Pre 2.7 PrePost P value I 1,1 / I 1,0 0.46 ± 0.15 (6) 0.56 ± 0.25 (6) 0.261 (5) 0.54 ± 0.21 (20) 0.85 ± 0.55 (14) 0.001* (13) 0.873 (3) 0.53 ± 0.26 (11) 1.10 ± 0.85 (14) <0.001 * (10) S M3 (nm) 14.361 ± 0.068 (9) 14.371 ± 0.039 (7) 0.732 (7) 14.390 ± 0.034 (21) 14.419 ± 0.043 (15) 0.029* (13) 0.033* (6) 14.400 ± 0.028 (14) 14.427 ± 0.031 (14) 0.005 * (11) I M3 (a.u.) 503 ± 151 (9) 435 ± 153 (7) 0.264 (7) 590 ± 166 (21) 518 ± 180 (15) 0.134 (13) 0.083 (6) 486 ± 102 (14) 399 ± 141 (14) 0.008 * (11) S M6 (nm) 7.220 ± 0.010 (5) 7.229 ± 0.005 (3) 0.032* (2) 7.229 ± 0.009 (13) 7.238 ± 0.009 (9) 0.004* (7) 0.085 (3) 7.234 ± 0.009 (12) 7.242 ± 0.008 (13) 0.046 * (8) d 1,0 (nm) 41.409 ± 1.776 (8) 41.763 ± 1.644 (7) 0.472 (7) 39.737 ± 2.340 (20) 39.584 ± 1.764 (13) 0.686 (12) 0.080 (5) 39.447 ± 2.148 (11) 40.246 ± 1.914 (14) 0.132 (10) Note: The table shows outcomes related to resting thick‐filament structure from MyoXRD experiments performed pre/post‐incubation in piperine (50 µm). A subgroup of EDL bundles was tested pre/post at sarcomere lengths (SL) of 2.4 and 2.7 µm; otherwise, all experiments were performed at SL 2.7 µm. The presented measures are: (1) the equatorial intensity ratio describing mass distribution around the thin and thick filaments (I 1,1/I 1,0) and (2) the spacing and the intensity of the M3 reflection (S M3 and I M3) describing the average distance between consecutive myosin heads (∼14.3 nm) and the degree of myosin‐head ordering. Furthermore, recent data show that the I M3 also arises from a significant contribution from the regulatory protein of myosin‐binding protein C (MyBP‐C). Additional outcomes are: (3) the spacing of the M6 reflection (S M6), reflecting myosin‐head spacing and intrinsic properties of the thick filament, and (4) the inter‐thick‐filament lattice spacing (d 1,0). Values are presented as model‐based mean ± observed SD. The following outcomes were log‐transformed for statistical analysis: EDL: I 1,1/I 1,0, S M3 and I M3; soleus: I 1,1/I 1,0. P values were calculated using a linear mixed‑effects model with treatment (pre vs. post) as fixed effect and sample as random effect, corresponding to a paired analysis. *Statistically significant differences (P ≤ 0.05) are shown in bold. The number in braces below the means show the number of data points, whereas the number below P values shows the number of pairs in the statistical analysis. Effects of piperine on resting thick‐filament structure of fast (extensor digitorum longus, EDL) and slow (soleus) rat fibres Pre 2.4 vs. Pre 2.7 0.46 ± 0.15 (6) 0.56 ± 0.25 (6) 0.261 (5) 0.54 ± 0.21 (20) 0.85 ± 0.55 (14) 0.001* (13) 0.873 (3) 0.53 ± 0.26 (11) 1.10 ± 0.85 (14) <0.001 * (10) S M3 (nm) 14.361 ± 0.068 (9) 14.371 ± 0.039 (7) 0.732 (7) 14.390 ± 0.034 (21) 14.419 ± 0.043 (15) 0.029* (13) 0.033* (6) 14.400 ± 0.028 (14) 14.427 ± 0.031 (14) 0.005 * (11) I M3 (a.u.) 503 ± 151 (9) 435 ± 153 (7) 0.264 (7) 590 ± 166 (21) 518 ± 180 (15) 0.134 (13) 0.083 (6) 486 ± 102 (14) 399 ± 141 (14) 0.008 * (11) S M6 (nm) 7.220 ± 0.010 (5) 7.229 ± 0.005 (3) 0.032* (2) 7.229 ± 0.009 (13) 7.238 ± 0.009 (9) 0.004* (7) 0.085 (3) 7.234 ± 0.009 (12) 7.242 ± 0.008 (13) 0.046 * (8) d 1,0 (nm) 41.409 ± 1.776 (8) 41.763 ± 1.644 (7) 0.472 (7) 39.737 ± 2.340 (20) 39.584 ± 1.764 (13) 0.686 (12) 0.080 (5) 39.447 ± 2.148 (11) 40.246 ± 1.914 (14) 0.132 (10) Note: The table shows outcomes related to resting thick‐filament structure from MyoXRD experiments performed pre/post‐incubation in piperine (50 µm). A subgroup of EDL bundles was tested pre/post at sarcomere lengths (SL) of 2.4 and 2.7 µm; otherwise, all experiments were performed at SL 2.7 µm. The presented measures are: (1) the equatorial intensity ratio describing mass distribution around the thin and thick filaments (I 1,1/I 1,0) and (2) the spacing and the intensity of the M3 reflection (S M3 and I M3) describing the average distance between consecutive myosin heads (∼14.3 nm) and the degree of myosin‐head ordering. Furthermore, recent data show that the I M3 also arises from a significant contribution from the regulatory protein of myosin‐binding protein C (MyBP‐C). Additional outcomes are: (3) the spacing of the M6 reflection (S M6), reflecting myosin‐head spacing and intrinsic properties of the thick filament, and (4) the inter‐thick‐filament lattice spacing (d 1,0). Values are presented as model‐based mean ± observed SD. The following outcomes were log‐transformed for statistical analysis: EDL: I 1,1/I 1,0, S M3 and I M3; soleus: I 1,1/I 1,0. P values were calculated using a linear mixed‑effects model with treatment (pre vs. post) as fixed effect and sample as random effect, corresponding to a paired analysis. *Statistically significant differences (P ≤ 0.05) are shown in bold. The number in braces below the means show the number of data points, whereas the number below P values shows the number of pairs in the statistical analysis. Table A2Effects of piperine on force and force kinetics in extensor digitorum longus (EDL) rat skeletal muscles during isometric twitch (2 Hz), unfused tetani (50 Hz), and fused tetani (150 Hz)Incubation time (min)Stimulation frequency (Hz)Peak force (mN)RFD (N s−1)Relaxation t 1/2 (ms)Vehicle (a)Piperine (b) P valueVehiclePiperine P valueVehiclePiperine P value Incubation 1 0 (pre) 2 (twitch) 50 (unfused) 150 (fused) 111 ± 17 395 ± 72 902 ± 153 104 ± 18 363 ± 70 908 ± 90 – – – 6.58 ± 1.1 6.75 ± 1.1 24.97 ± 4.7 6.10 ± 1.1 6.40 ± 1.0 22.54 ± 2.1 – – – 14.92 ± 0.49 32.25 ± 0.52 39.33 ± 1.54 14.50 ± 0.35 31.20 ± 0.91 38.60 ± 1.85 – – – 20 2 50 150 108 ± 16 384 ± 72 890 ± 149* 116 ± 19 * 399 ± 76 * 888 ± 90# 0.002 0.017 0.038 6.43 ± 1.0 6.62 ± 1.0 24.05 ± 4.6 6.70 ± 1.0 * 7.08 ± 1.0 * 22.66 ± 2.1 <0.001 0.003 0.314 14.25 ± 0.27 31.83 ± 0.52 40.00 ± 1.22 14.10 ± 0.42 31.60 ± 0.82 * 40.20 ± 1.96 >0.999 0.004 0.217 40 2 50 150 108 ± 16 388 ± 72 879 ± 148 129 ± 17 * 454 ± 74 * 871 ± 94 <0.001 <0.001 0.091 6.42 ± 1.0 6.63 ± 1.0 24.07 ± 4.6 7.48 ± 1.0 * 7.94 ± 1.0 * 22.86 ± 2.1 * <0.001 <0.001 0.008 14.33 ± 0.26 32.00 ± 0.55 40.42 ± 1.32 14.40 ± 0.42 32.20 ± 1.04 * 41.50 ± 1.94 * 0.184 <0.001 0.002 60 2 50 150 108 ± 18 387 ± 75 868 ± 149 137 ± 18 * 492 ± 75 * 856 ± 101 <0.001 <0.001 0.134 6.47 ± 1.1 6.65 ± 1.1 24.08 ± 4.5 8.02 ± 1.0 * 8.48 ± 1.1 * 23.04 ± 2.1 * <0.001 <0.001 <0.001 14.50 ± 0.32 32.17 ± 0.52 40.67 ± 1.17 14.50 ± 0.35 32.80 ± 0.91 * 42.70 ± 1.79 * 0.414 <0.001 <0.001 Assessment of dynamic muscle function including rest (90 min)Piperine (a)Wash‐out (b) P valuePiperineWash‐out P valuePiperineWash‐out P value Incubation 2 0 (pre) (150 min) 2 50 150 101 ± 16# 368 ± 74# 835 ± 134 149 ± 22 547 ± 77 826 ± 93 <0.001 <0.001 0.414 6.05 ± 1.0# 6.23 ± 1.1# 23.47 ± 4.3# 8.68 ± 1.3 9.18 ± 1.3 22.76 ± 2.0 <0.001 <0.001 <0.001 14.58 ± 0.20# 32.50 ± 0.55# 41.08 ± 1.02# 15.00 ± 0.00 34.10 ± 0.89 44.30 ± 1.61 0.002 <0.001 <0.001 20 2 50 150 112 ± 18# 404 ± 84# 813 ± 130 136 ± 20 487 ± 74 825 ± 92 <0.001 <0.001 0.873 6.75 ± 1.1# 6.92 ± 1.1# 23.47 ± 4.3# 7.98 ± 1.2 8.44 ± 1.1 22.76 ± 2.1 <0.001 <0.001 <0.001 14.50 ± 0.32 32.58 ± 0.74# 42.50 ± 0.89 14.00 ± 0.22 33.10 ± 0.65 42.90 ± 1.43 >0.999 <0.001 0.073 40 2 50 150 124 ± 22# 460 ± 90# 808 ± 128 127 ± 20 453 ± 77 823 ± 91 0.032 0.023 0.897 7.37 ± 1.3# 7.78 ± 1.4# 23.58 ± 4.2# 7.48 ± 1.2 7.96 ± 1.1 22.76 ± 2.1 0.003 0.021 <0.001 14.92 ± 0.38 33.25 ± 0.88 43.75 ± 1.07 14.30 ± 0.27 32.60 ± 0.96 42.10 ± 1.39 >0.999 >0.999 0.267 60 2 50 150 134 ± 24 495 ± 94 804 ± 126 122 ± 20 428 ± 80 817 ± 90 >0.999 0.054 0.931 7.90 ± 1.4 8.45 ± 1.5 23.70 ± 4.2# 7.26 ± 1.2 7.64 ± 1.1 22.68 ± 2.1 0.802 0.199 0.003 14.75 ± 0.61 33.42 ± 0.97 44.75 ± 0.99 * 14.00 ± 0.35 32.20 ± 1.15 41.80 ± 1.40 0.953 >0.999 <0.001 Note: The table shows force (millinewton) and peak force development (rate of force development, RFD) (N s−1) and relaxation halftime (t 1/2) (ms) derived from EDL muscles for two 1 h incubations. Contralateral muscles were exposed to two distinct incubation sequences (explained in Fig. 1B ), exposing muscles to vehicle, piperine (50 µm), or a wash‐out (fresh Krebs‐Ringer). In the latter incubation, we investigated the ability to reverse the effects of piperine by a wash‐out (substitution of KR buffer at 0, 5, 15 and 25 min) as well as the reproducibility of piperine's effects in the contralateral muscle. Values in bold with asterisk (*) and hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than the opposite treatment at the given time point (P ≤ 0.05). This was analysed using mixed effects models, analysing the effects of treatment, time point and the interaction between treatment × time point; n = 6 muscles in sequence (a) and n = 5 muscles in sequence (b). Values are presented as the mean ± SD. Effects of piperine on force and force kinetics in extensor digitorum longus (EDL) rat skeletal muscles during isometric twitch (2 Hz), unfused tetani (50 Hz), and fused tetani (150 Hz) 2 (twitch) 50 (unfused) 150 (fused) 111 ± 17 395 ± 72 902 ± 153 104 ± 18 363 ± 70 908 ± 90 – – – 6.58 ± 1.1 6.75 ± 1.1 24.97 ± 4.7 6.10 ± 1.1 6.40 ± 1.0 22.54 ± 2.1 – – – 14.92 ± 0.49 32.25 ± 0.52 39.33 ± 1.54 14.50 ± 0.35 31.20 ± 0.91 38.60 ± 1.85 – – – 2 50 150 108 ± 16 384 ± 72 890 ± 149* 116 ± 19 * 399 ± 76 * 888 ± 90# 0.002 0.017 0.038 6.43 ± 1.0 6.62 ± 1.0 24.05 ± 4.6 6.70 ± 1.0 * 7.08 ± 1.0 * 22.66 ± 2.1 <0.001 0.003 0.314 14.25 ± 0.27 31.83 ± 0.52 40.00 ± 1.22 14.10 ± 0.42 31.60 ± 0.82 * 40.20 ± 1.96 >0.999 0.004 0.217 2 50 150 108 ± 16 388 ± 72 879 ± 148 129 ± 17 * 454 ± 74 * 871 ± 94 <0.001 <0.001 0.091 6.42 ± 1.0 6.63 ± 1.0 24.07 ± 4.6 7.48 ± 1.0 * 7.94 ± 1.0 * 22.86 ± 2.1 * <0.001 <0.001 0.008 14.33 ± 0.26 32.00 ± 0.55 40.42 ± 1.32 14.40 ± 0.42 32.20 ± 1.04 * 41.50 ± 1.94 * 0.184 <0.001 0.002 2 50 150 108 ± 18 387 ± 75 868 ± 149 137 ± 18 * 492 ± 75 * 856 ± 101 <0.001 <0.001 0.134 6.47 ± 1.1 6.65 ± 1.1 24.08 ± 4.5 8.02 ± 1.0 * 8.48 ± 1.1 * 23.04 ± 2.1 * <0.001 <0.001 <0.001 14.50 ± 0.32 32.17 ± 0.52 40.67 ± 1.17 14.50 ± 0.35 32.80 ± 0.91 * 42.70 ± 1.79 * 0.414 <0.001 <0.001 0 (pre) (150 min) 2 50 150 101 ± 16# 368 ± 74# 835 ± 134 149 ± 22 547 ± 77 826 ± 93 <0.001 <0.001 0.414 6.05 ± 1.0# 6.23 ± 1.1# 23.47 ± 4.3# 8.68 ± 1.3 9.18 ± 1.3 22.76 ± 2.0 <0.001 <0.001 <0.001 14.58 ± 0.20# 32.50 ± 0.55# 41.08 ± 1.02# 15.00 ± 0.00 34.10 ± 0.89 44.30 ± 1.61 0.002 <0.001 <0.001 2 50 150 112 ± 18# 404 ± 84# 813 ± 130 136 ± 20 487 ± 74 825 ± 92 <0.001 <0.001 0.873 6.75 ± 1.1# 6.92 ± 1.1# 23.47 ± 4.3# 7.98 ± 1.2 8.44 ± 1.1 22.76 ± 2.1 <0.001 <0.001 <0.001 14.50 ± 0.32 32.58 ± 0.74# 42.50 ± 0.89 14.00 ± 0.22 33.10 ± 0.65 42.90 ± 1.43 >0.999 <0.001 0.073 2 50 150 124 ± 22# 460 ± 90# 808 ± 128 127 ± 20 453 ± 77 823 ± 91 0.032 0.023 0.897 7.37 ± 1.3# 7.78 ± 1.4# 23.58 ± 4.2# 7.48 ± 1.2 7.96 ± 1.1 22.76 ± 2.1 0.003 0.021 <0.001 14.92 ± 0.38 33.25 ± 0.88 43.75 ± 1.07 14.30 ± 0.27 32.60 ± 0.96 42.10 ± 1.39 >0.999 >0.999 0.267 2 50 150 134 ± 24 495 ± 94 804 ± 126 122 ± 20 428 ± 80 817 ± 90 >0.999 0.054 0.931 7.90 ± 1.4 8.45 ± 1.5 23.70 ± 4.2# 7.26 ± 1.2 7.64 ± 1.1 22.68 ± 2.1 0.802 0.199 0.003 14.75 ± 0.61 33.42 ± 0.97 44.75 ± 0.99 * 14.00 ± 0.35 32.20 ± 1.15 41.80 ± 1.40 0.953 >0.999 <0.001 Note: The table shows force (millinewton) and peak force development (rate of force development, RFD) (N s−1) and relaxation halftime (t 1/2) (ms) derived from EDL muscles for two 1 h incubations. Contralateral muscles were exposed to two distinct incubation sequences (explained in Fig. 1B ), exposing muscles to vehicle, piperine (50 µm), or a wash‐out (fresh Krebs‐Ringer). In the latter incubation, we investigated the ability to reverse the effects of piperine by a wash‐out (substitution of KR buffer at 0, 5, 15 and 25 min) as well as the reproducibility of piperine's effects in the contralateral muscle. Values in bold with asterisk (*) and hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than the opposite treatment at the given time point (P ≤ 0.05). This was analysed using mixed effects models, analysing the effects of treatment, time point and the interaction between treatment × time point; n = 6 muscles in sequence (a) and n = 5 muscles in sequence (b). Values are presented as the mean ± SD. Table A3Effects of piperine on force and force kinetics in slow soleus rat skeletal muscles during isometric twitch (2 Hz), unfused tetani (20 Hz) and fused tetani (80 Hz) Incubation time (min) Stimulation frequency (Hz)Peak force (mN)RFD (N s−1)Relaxation t 1/2 (ms)Vehicle (a)Piperine (b) P valueVehiclePiperine P valueVehiclePiperine P value Incubation 1 0 (pre) 2 (twitch) 20 (unfused) 80 (fused) 49 ± 14 257 ± 84 463 ± 87 54 ± 14 305 ± 57 529 ± 93 – – – 1.91 ± 0.4 1.94 ± 0.4 4.13 ± 0.9 2.10 ± 0.6 2.13 ± 0.6 4.87 ± 0.9 – – – 35.43 ± 5.01 111.83 ± 10.77 105.33 ± 6.33 37.08 ± 3.63 116.75 ± 7.39 106.67 ± 2.32 – – – 10 2 20 80 47 ± 14 258 ± 83 465 ± 89 57 ± 15 * 320 ± 58 * 535 ± 97 <0.001 0.009 0.413 1.84 ± 0.4 1.87 ± 0.4 4.14 ± 0.9 2.20 ± 0.6 * 2.23 ± 0.6 * 5.13 ± 0.9 * 0.002 0.002 0.002 35.67 ± 4.40 112.50 ± 10.64 105.92 ± 6.38 38.75 ± 3.42 111.42 ± 5.53# 104.33 ± 2.44# >0.999 <0.001 0.005 20 2 20 80 47 ± 14 256 ± 83 464 ± 89 61 ± 16 * 329 ± 57 * 539 ± 100 <0.001 0.005 0.294 1.84 ± 0.4 1.88 ± 0.4 4.16 ± 0.9 2.34 ± 0.7 * 2.40 ± 0.6 * 5.34 ± 1.0 * <0.001 <0.001 <0.001 34.67 ± 4.45 111.75 ± 10.82 106.42 ± 6.63 38.92 ± 3.50* 108.33 ± 4.97# 104.17 ± 2.09# 0.017 <0.001 <0.001 30 2 20 80 47 ± 14 256 ± 82 463 ± 89 65 ± 17 * 340 ± 57 * 539 ± 100 <0.001 0.003 0.309 1.84 ± 0.4 1.85 ± 0.4 4.16 ± 1.0 2.48 ± 0.7 * 2.54 ± 0.7 * 5.44 ± 1.0 * <0.001 <0.001 <0.001 35.33 ± 4.48 111.50 ± 10.59 106.33 ± 6.59 39.83 ± 3.71* 107.33 ± 4.33# 104.33 ± 2.18# 0.011 <0.001 <0.001 40 2 20 80 46 ± 14 253 ± 82 462 ± 90 68 ± 17 * 347 ± 57 * 537 ± 100 <0.001 0.001 0.371 1.82 ± 0.5 1.85 ± 0.4 4.16 ± 1.0 2.54 ± 0.7 * 2.62 ± 0.7 * 5.52 ± 1.0 * <0.001 <0.001 <0.001 34.42 ± 4.31 111.17 ± 10.34 106.33 ± 6.59 39.08 ± 4.16* 107.00 ± 3.89# 105.25 ± 1.94# 0.005 <0.001 0.026 50 2 20 80 46 ± 14 251 ± 82 461 ± 90 72 ± 20 * 353 ± 57 * 535 ± 101 <0.001 0.001 0.475 1.81 ± 0.5 1.82 ± 0.4 4.13 ± 1.0 2.59 ± 0.8 * 2.70 ± 0.7 * 5.59 ± 1.0 * <0.001 <0.001 <0.001 34.58 ± 4.45 111.00 ± 10.39 106.18 ± 6.41 39.75 ± 4.07* 107.25 ± 3.63# 106.08 ± 2.04 <0.001 <0.001 0.694 60 2 20 80 45 ± 14 248 ± 82 459 ± 90 72 ± 19 * 357 ± 59 * 531 ± 100 <0.001 <0.001 0.548 1.80 ± 0.5 1.82 ± 0.4 4.15 ± 1.0 2.64 ± 0.8 * 2.76 ± 0.7 * 5.65 ± 1.0 * <0.001 <0.001 <0.001 33.92 ± 4.22 111.50 ± 10.38 106.25 ± 6.46 40.25 ± 4.11* 107.83 ± 3.17# 107.08 ± 2.13 <0.001 <0.001 >0.999 Assessment of dynamic muscle function including rest (90 min)Piperine (a)Wash‐out (b) P valuePiperineWash‐out P valuePiperineWash‐out P value Incubation 2 0 (pre) (150 min) 2 20 80 44 ± 13# 242 ± 80# 438 ± 100 72 ± 20 366 ± 62 510 ± 99 <0.001 <0.001 0.295 1.75 ± 0.5# 1.81 ± 0.4# 4.08 ± 1.1# 2.64 ± 0.8 2.79 ± 0.8 5.44 ± 1.0 <0.001 <0.001 <0.001 32.92 ± 4.07# 111.25 ± 10.38 106.92 ± 6.34# 41.75 ± 4.82 114.92 ± 3.28 115.42 ± 2.46 <0.001 >0.999 <0.001 10 2 20 80 49 ± 14# 250 ± 77# 437 ± 101 67 ± 20 354 ± 63 510 ± 99 <0.001 0.001 0.288 1.90 ± 0.5# 1.92 ± 0.5# 4.31 ± 1.1# 2.46 ± 0.8 2.57 ± 0.7 5.30 ± 1.1 <0.001 <0.001 0.002 33.83 ± 3.36# 105.00 ± 8.16# 102.58 ± 5.70# 40.67 ± 3.72 115.00 ± 3.32 113.17 ± 2.84 <0.001 <0.001 <0.001 20 2 20 80 54 ± 15 262 ± 77 # 457 ± 119 63 ± 19 338 ± 61 508 ± 98 0.148 0.033 0.483 2.09 ± 0.5 2.11 ± 0.5# 4.46 ± 1.2 2.36 ± 0.8 2.45 ± 0.8 5.16 ± 1.0 0.425 0.043 0.368 34.75 ± 3.13# 103.75 ± 7.15# 103.25 ± 5.39# 39.00 ± 3.58 115.00 ± 3.82 112.67 ± 2.96 0.035 <0.001 <0.001 30 2 20 80 58 ± 15 273 ± 77 440 ± 101 59 ± 19 331 ± 58 507 ± 98 0.096 0.748 0.613 2.19 ± 0.6 * 2.21 ± 0.5 * 4.56 ± 1.2 * 2.22 ± 0.8 2.32 ± 0.8 5.05 ± 1.0 <0.001 0.032 <0.001 35.67 ± 3.52 103.75 ± 6.75# 104.33 ± 5.21# 38.25 ± 2.16 115.08 ± 4.01 111.92 ± 2.78 >0.999 <0.001 <0.001 40 2 20 80 60 ± 16 * 279 ± 77 437 ± 99 58 ± 19 320 ± 59 507 ± 97 0.036 0.196 0.435 2.24 ± 0.5 * 2.30 ± 0.5 * 4.64 ± 1.3 * 2.19 ± 0.8 2.26 ± 0.7 4.98 ± 1.0 <0.001 <0.001 <0.001 36.17 ± 3.40 104.50 ± 6.62# 105.50 ± 5.17# 36.25 ± 2.25 114.67 ± 4.22 111.42 ± 2.67 0.529 <0.001 <0.001 50 2 20 80 61 ± 18 * 284 ± 78 * 434 ± 99 56 ± 18 314 ± 58 507 ± 95 0.010 0.047 0.261 2.26 ± 0.6 * 2.33 ± 0.6 * 4.67 ± 1.3 * 2.18 ± 0.7 2.23 ± 0.7 4.92 ± 1.0 <0.001 <0.001 <0.001 36.67 ± 3.42 105.17 ± 6.38# 106.42 ± 4.95# 36.75 ± 3.11 114.67 ± 4.61 110.83 ± 2.77 0.301 <0.001 0.002 60 2 20 80 62 ± 18 * 286 ± 79 * 430 ± 99 54 ± 18 306 ± 57 506 ± 94 0.005 0.016 0.163 2.29 ± 0.6 * 2.36 ± 0.6 * 4.66 ± 1.3 * 2.12 ± 0.7 2.16 ± 0.7 4.84 ± 1.0 <0.001 <0.001 <0.001 37.17 ± 4.00 106.17 ± 6.17# 107.67 ± 4.95 35.42 ± 2.18 114.58 ± 5.07 110.58 ± 2.54 <0.001 0.029 >0.999 Note: Similar to Table A2 above, the table shows peak force, peak force development, and force relaxation halftime from two 1 h incubations (Fig. 1B ), although for the soleus muscles. Values in bold with an asterisk (*) and a hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than the opposite treatment at the given time point (P ≤ 0.05). This was analysed using two‐way ANOVA, analysing the effects of treatment, time point and the interaction between treatment × time point; n = 6 muscles in sequences (a) and (b), respectively. Values are presented as the mean ± SD. Effects of piperine on force and force kinetics in slow soleus rat skeletal muscles during isometric twitch (2 Hz), unfused tetani (20 Hz) and fused tetani (80 Hz) Incubation time (min) 2 (twitch) 20 (unfused) 80 (fused) 49 ± 14 257 ± 84 463 ± 87 54 ± 14 305 ± 57 529 ± 93 – – – 1.91 ± 0.4 1.94 ± 0.4 4.13 ± 0.9 2.10 ± 0.6 2.13 ± 0.6 4.87 ± 0.9 – – – 35.43 ± 5.01 111.83 ± 10.77 105.33 ± 6.33 37.08 ± 3.63 116.75 ± 7.39 106.67 ± 2.32 – – – 2 20 80 47 ± 14 258 ± 83 465 ± 89 57 ± 15 * 320 ± 58 * 535 ± 97 <0.001 0.009 0.413 1.84 ± 0.4 1.87 ± 0.4 4.14 ± 0.9 2.20 ± 0.6 * 2.23 ± 0.6 * 5.13 ± 0.9 * 0.002 0.002 0.002 35.67 ± 4.40 112.50 ± 10.64 105.92 ± 6.38 38.75 ± 3.42 111.42 ± 5.53# 104.33 ± 2.44# >0.999 <0.001 0.005 2 20 80 47 ± 14 256 ± 83 464 ± 89 61 ± 16 * 329 ± 57 * 539 ± 100 <0.001 0.005 0.294 1.84 ± 0.4 1.88 ± 0.4 4.16 ± 0.9 2.34 ± 0.7 * 2.40 ± 0.6 * 5.34 ± 1.0 * <0.001 <0.001 <0.001 34.67 ± 4.45 111.75 ± 10.82 106.42 ± 6.63 38.92 ± 3.50* 108.33 ± 4.97# 104.17 ± 2.09# 0.017 <0.001 <0.001 2 20 80 47 ± 14 256 ± 82 463 ± 89 65 ± 17 * 340 ± 57 * 539 ± 100 <0.001 0.003 0.309 1.84 ± 0.4 1.85 ± 0.4 4.16 ± 1.0 2.48 ± 0.7 * 2.54 ± 0.7 * 5.44 ± 1.0 * <0.001 <0.001 <0.001 35.33 ± 4.48 111.50 ± 10.59 106.33 ± 6.59 39.83 ± 3.71* 107.33 ± 4.33# 104.33 ± 2.18# 0.011 <0.001 <0.001 2 20 80 46 ± 14 253 ± 82 462 ± 90 68 ± 17 * 347 ± 57 * 537 ± 100 <0.001 0.001 0.371 1.82 ± 0.5 1.85 ± 0.4 4.16 ± 1.0 2.54 ± 0.7 * 2.62 ± 0.7 * 5.52 ± 1.0 * <0.001 <0.001 <0.001 34.42 ± 4.31 111.17 ± 10.34 106.33 ± 6.59 39.08 ± 4.16* 107.00 ± 3.89# 105.25 ± 1.94# 0.005 <0.001 0.026 2 20 80 46 ± 14 251 ± 82 461 ± 90 72 ± 20 * 353 ± 57 * 535 ± 101 <0.001 0.001 0.475 1.81 ± 0.5 1.82 ± 0.4 4.13 ± 1.0 2.59 ± 0.8 * 2.70 ± 0.7 * 5.59 ± 1.0 * <0.001 <0.001 <0.001 34.58 ± 4.45 111.00 ± 10.39 106.18 ± 6.41 39.75 ± 4.07* 107.25 ± 3.63# 106.08 ± 2.04 <0.001 <0.001 0.694 2 20 80 45 ± 14 248 ± 82 459 ± 90 72 ± 19 * 357 ± 59 * 531 ± 100 <0.001 <0.001 0.548 1.80 ± 0.5 1.82 ± 0.4 4.15 ± 1.0 2.64 ± 0.8 * 2.76 ± 0.7 * 5.65 ± 1.0 * <0.001 <0.001 <0.001 33.92 ± 4.22 111.50 ± 10.38 106.25 ± 6.46 40.25 ± 4.11* 107.83 ± 3.17# 107.08 ± 2.13 <0.001 <0.001 >0.999 0 (pre) (150 min) 2 20 80 44 ± 13# 242 ± 80# 438 ± 100 72 ± 20 366 ± 62 510 ± 99 <0.001 <0.001 0.295 1.75 ± 0.5# 1.81 ± 0.4# 4.08 ± 1.1# 2.64 ± 0.8 2.79 ± 0.8 5.44 ± 1.0 <0.001 <0.001 <0.001 32.92 ± 4.07# 111.25 ± 10.38 106.92 ± 6.34# 41.75 ± 4.82 114.92 ± 3.28 115.42 ± 2.46 <0.001 >0.999 <0.001 2 20 80 49 ± 14# 250 ± 77# 437 ± 101 67 ± 20 354 ± 63 510 ± 99 <0.001 0.001 0.288 1.90 ± 0.5# 1.92 ± 0.5# 4.31 ± 1.1# 2.46 ± 0.8 2.57 ± 0.7 5.30 ± 1.1 <0.001 <0.001 0.002 33.83 ± 3.36# 105.00 ± 8.16# 102.58 ± 5.70# 40.67 ± 3.72 115.00 ± 3.32 113.17 ± 2.84 <0.001 <0.001 <0.001 2 20 80 54 ± 15 262 ± 77 # 457 ± 119 63 ± 19 338 ± 61 508 ± 98 0.148 0.033 0.483 2.09 ± 0.5 2.11 ± 0.5# 4.46 ± 1.2 2.36 ± 0.8 2.45 ± 0.8 5.16 ± 1.0 0.425 0.043 0.368 34.75 ± 3.13# 103.75 ± 7.15# 103.25 ± 5.39# 39.00 ± 3.58 115.00 ± 3.82 112.67 ± 2.96 0.035 <0.001 <0.001 2 20 80 58 ± 15 273 ± 77 440 ± 101 59 ± 19 331 ± 58 507 ± 98 0.096 0.748 0.613 2.19 ± 0.6 * 2.21 ± 0.5 * 4.56 ± 1.2 * 2.22 ± 0.8 2.32 ± 0.8 5.05 ± 1.0 <0.001 0.032 <0.001 35.67 ± 3.52 103.75 ± 6.75# 104.33 ± 5.21# 38.25 ± 2.16 115.08 ± 4.01 111.92 ± 2.78 >0.999 <0.001 <0.001 2 20 80 60 ± 16 * 279 ± 77 437 ± 99 58 ± 19 320 ± 59 507 ± 97 0.036 0.196 0.435 2.24 ± 0.5 * 2.30 ± 0.5 * 4.64 ± 1.3 * 2.19 ± 0.8 2.26 ± 0.7 4.98 ± 1.0 <0.001 <0.001 <0.001 36.17 ± 3.40 104.50 ± 6.62# 105.50 ± 5.17# 36.25 ± 2.25 114.67 ± 4.22 111.42 ± 2.67 0.529 <0.001 <0.001 2 20 80 61 ± 18 * 284 ± 78 * 434 ± 99 56 ± 18 314 ± 58 507 ± 95 0.010 0.047 0.261 2.26 ± 0.6 * 2.33 ± 0.6 * 4.67 ± 1.3 * 2.18 ± 0.7 2.23 ± 0.7 4.92 ± 1.0 <0.001 <0.001 <0.001 36.67 ± 3.42 105.17 ± 6.38# 106.42 ± 4.95# 36.75 ± 3.11 114.67 ± 4.61 110.83 ± 2.77 0.301 <0.001 0.002 2 20 80 62 ± 18 * 286 ± 79 * 430 ± 99 54 ± 18 306 ± 57 506 ± 94 0.005 0.016 0.163 2.29 ± 0.6 * 2.36 ± 0.6 * 4.66 ± 1.3 * 2.12 ± 0.7 2.16 ± 0.7 4.84 ± 1.0 <0.001 <0.001 <0.001 37.17 ± 4.00 106.17 ± 6.17# 107.67 ± 4.95 35.42 ± 2.18 114.58 ± 5.07 110.58 ± 2.54 <0.001 0.029 >0.999 Note: Similar to Table A2 above, the table shows peak force, peak force development, and force relaxation halftime from two 1 h incubations (Fig. 1B ), although for the soleus muscles. Values in bold with an asterisk (*) and a hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than the opposite treatment at the given time point (P ≤ 0.05). This was analysed using two‐way ANOVA, analysing the effects of treatment, time point and the interaction between treatment × time point; n = 6 muscles in sequences (a) and (b), respectively. Values are presented as the mean ± SD. Table A4 P values from analyses of contractile power and force across all contractions in low‐ and high‐frequency force–velocity (FV) relationships presented in Figs. 8 and 9.Main effects (treatment and relative load) and interactionEDLSoleusLow‐frequency (60 Hz)High‐frequency (150 Hz)Low‐frequency (20 Hz)High‐frequency (80 Hz)TreatmentLoadInteractionTreatmentLoadInteractionTreatmentLoadInteractionTreatmentLoadInteraction Power <0.001 <0.001 <0.001 0.560 <0.001 0.397 <0.001 <0.001 <0.001 0.004 <0.001 0.210 Post hoc analyses (paired t tests for isometric force)LoadForce–velocity relationshipsForce–velocity relationshipsForcePowerForcePowerForcePowerForcePower 5% – 0.008* – 0.028* – <0.001* – 0.007* 15% – 0.021* –>0.999– <0.001* – 0.001* 27.5% – 0.006 –0.594– <0.001 – 0.016* 40% – 0.011* –0.646– <0.001* –0.059 60% – 0.012* –0.603– <0.001* –>0.999 80% – 0.011* –>0.999– 0.003* –>0.999 100% 0.003* –0.319– <0.001* –0.751– Note: P values show main effects of treatment (piperine and vehicle), relative load (5%, 15%, 27.5%, 40%, 60%, 80% and 100% of initial F max), and their interaction (treatment × relative load) by two‐way ANOVAs (soleus) and mixed‐effects models (EDL). Lower panel: P values from post hoc tests comparing changes relative to baseline (FV1) in measured contractile power and force (paired t tests) from baseline between piperine and vehicle treatments (FV2) across all contractions (relative loads) in low‐ and high‐frequency FV relationships are shown. Values in bold with * indicate that muscles exposed to piperine increased more relative to baseline compared to the opposite treatment (P ≤ 0.05); EDL, n = 6 muscles exposed to vehicle and n = 5 exposed to piperine; Soleus, n = 6 muscles per treatment. P values from analyses of contractile power and force across all contractions in low‐ and high‐frequency force–velocity (FV) relationships presented in Figs. 8 and 9. Note: P values show main effects of treatment (piperine and vehicle), relative load (5%, 15%, 27.5%, 40%, 60%, 80% and 100% of initial F max), and their interaction (treatment × relative load) by two‐way ANOVAs (soleus) and mixed‐effects models (EDL). Lower panel: P values from post hoc tests comparing changes relative to baseline (FV1) in measured contractile power and force (paired t tests) from baseline between piperine and vehicle treatments (FV2) across all contractions (relative loads) in low‐ and high‐frequency FV relationships are shown. Values in bold with * indicate that muscles exposed to piperine increased more relative to baseline compared to the opposite treatment (P ≤ 0.05); EDL, n = 6 muscles exposed to vehicle and n = 5 exposed to piperine; Soleus, n = 6 muscles per treatment. Table A5Absolute Hill estimates from the three low‐frequency force–velocity tests (FV1‐3) F max (mN) V max (mm s−1) a/F o P max (mW)Incubation sequence a b a b a b a b EDL (60 Hz) FV1625.9 ± 123.3607.1 ± 69.170.0 ± 5.463.4 ± 5.00.65 ± 0.080.98 ± 0.115.63 ± 1.325.69 ± 1.04FV2565.2 ± 107.9 691.4 ± 66.5 * 67.8 ± 5.5 76.8 ± 5.9 * 0.73 ± 0.12 0.76 ± 0.19# 5.29 ± 1.10 7.29 ± 0.85 * FV3 665.8 ± 113.1 * 579.0 ± 81.3 84.3 ± 8.1 * 65.8 ± 4.5 0.55 ± 0.12 # 0.96 ± 0.22 6.77 ± 1.27 * 5.92 ± 0.88 Soleus (20 Hz) FV1276.5 ± 88.4323.0 ± 60.246.4 ± 13.835.9 ± 11.00.16 ± 0.030.22 ± 0.040.67 ± 0.270.85 ± 0.26FV2254.0 ± 82.2 377.1 ± 62.0 * 41.2 ± 11.1 38.6 ± 9.5 * 0.17 ± 0.030.24 ± 0.040.57 ± 0.25 1.17 ± 0.32 * FV3 292.8 ± 79.3 * 292.4 ± 55.044.3 ± 11.036.3 ± 5.80.19 ± 0.030.21 ± 0.04 0.82 ± 0.32 * 0.72 ± 0.26 Note: The table shows Hill's estimates of low‐frequency maximal isometric force (F max), maximal unloaded shortening velocity (V max), a/F o, which is inversely related to the curvature of the force–velocity (FV) curve, and maximal contraction power (P max). Estimates are derived from extensor digitorum longus (EDL) and soleus muscles performing three FV tests (FV1–3), at low‐frequency electrical stimulation (EDL: 60 Hz; soleus: 20 Hz) (Fig. 1B ). FV1 was baseline testing with all muscles incubated in standard Krebs‐Ringer buffer. In FV2, muscles in incubation sequences (a) and (b) were incubated in vehicle (0.1% ethanol 96%) and piperine (50 µm), respectively. In FV3, muscles in groups (a) and (b) were exposed to piperine (50 µm) and wash‐out (fresh Krebs‐Ringer), respectively. Values in bold with an asterisk (*) and a hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relative to baseline than the opposite treatment (P ≤ 0.05) using paired t tests. P values are shown in Table A7; n = 5 pairs of EDL muscles and n = 6 pairs of soleus muscles. Values are shown as the group mean ± SD based on pairs. Absolute Hill estimates from the three low‐frequency force–velocity tests (FV1‐3) Note: The table shows Hill's estimates of low‐frequency maximal isometric force (F max), maximal unloaded shortening velocity (V max), a/F o, which is inversely related to the curvature of the force–velocity (FV) curve, and maximal contraction power (P max). Estimates are derived from extensor digitorum longus (EDL) and soleus muscles performing three FV tests (FV1–3), at low‐frequency electrical stimulation (EDL: 60 Hz; soleus: 20 Hz) (Fig. 1B ). FV1 was baseline testing with all muscles incubated in standard Krebs‐Ringer buffer. In FV2, muscles in incubation sequences (a) and (b) were incubated in vehicle (0.1% ethanol 96%) and piperine (50 µm), respectively. In FV3, muscles in groups (a) and (b) were exposed to piperine (50 µm) and wash‐out (fresh Krebs‐Ringer), respectively. Values in bold with an asterisk (*) and a hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relative to baseline than the opposite treatment (P ≤ 0.05) using paired t tests. P values are shown in Table A7; n = 5 pairs of EDL muscles and n = 6 pairs of soleus muscles. Values are shown as the group mean ± SD based on pairs. Table A6Absolute Hill estimates from the three high‐frequency force–velocity tests (FV1–3) F max (mN) V max (mm s−1) a/F o P max (mW)Incubation sequenceabababAb EDL (150 Hz) FV1919.5 ± 167.5955.4 ± 88.6136.0 ± 4.1132.1 ± 4.20.39 ± 0.040.45 ± 0.0314.25 ± 3.1714.94 ± 1.98FV2833.6 ± 146.9848.4 ± 99.8135.0 ± 3.0 137.9 ± 2.8 * 0.43 ± 0.04 0.44 ± 0.02# 13.63 ± 2.83 13.96 ± 1.79 # FV3790.5 ± 132.5818.4 ± 90.4140.0 ± 3.0133.7 ± 3.20.40 ± 0.040.48 ± 0.0513.02 ± 2.5513.64 ± 1.64 Soleus (80 Hz) FV1464.7 ± 98.6563.0 ± 93.651.5 ± 6.353.6 ± 12.60.16 ± 0.020.20 ± 0.021.82 ± 0.592.40 ± 0.61FV2443.1 ± 97.0515.0 ± 98.551.3 ± 7.7 58.0 ± 12.8 * 0.17 ± 0.020.19 ± 0.031.75 ± 0.59 2.54 ± 0.53 * FV3 408.2 ± 92.6# 501.9 ± 85.555.5 ± 8.454.7 ± 11.60.17 ± 0.010.19 ± 0.031.83 ± 0.642.26 ± 0.60 Note: Similar to Table A5 above, the table shows Hill's estimates of F max, V max, a/F o which is inversely related to the curvature of the FV curve, and P max. In this table, estimates are derived from extensor digitorum longus (EDL) and soleus muscles, during high‐frequency stimulation (EDL: 150 Hz; soleus: 80 Hz). The setup is identical to Table A5 above.Values in bold with an asterisk (*) and hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than the opposite treatment (P ≤ 0.05) using paired t tests. P values are shown in Table A7; n = 5 pairs of EDL muscles and n = 6 pairs of soleus muscles. Values are shown as the group mean ± SD based on pairs. Absolute Hill estimates from the three high‐frequency force–velocity tests (FV1–3) Note: Similar to Table A5 above, the table shows Hill's estimates of F max, V max, a/F o which is inversely related to the curvature of the FV curve, and P max. In this table, estimates are derived from extensor digitorum longus (EDL) and soleus muscles, during high‐frequency stimulation (EDL: 150 Hz; soleus: 80 Hz). The setup is identical to Table A5 above. Values in bold with an asterisk (*) and hash symbol (#) indicate that muscles exposed to piperine increased or decreased more, respectively, relatively to baseline than the opposite treatment (P ≤ 0.05) using paired t tests. P values are shown in Table A7; n = 5 pairs of EDL muscles and n = 6 pairs of soleus muscles. Values are shown as the group mean ± SD based on pairs. Table A7 P values from paired t tests comparing Hill estimates between treatments from the three low‐ and high‐frequency force–velocity tests (FV1–3) presented in Tables A5 and A6 F max V max a/F o P max EDL (60 Hz) FV1 (baseline)––––FV2 (vehicle vs. piperine) 0.003* 0.002* <0.001 0.002* FV3 (piperine vs. wash‐out) 0.012* <0.001* 0.004# <0.001* Soleus (20 Hz) FV1 (baseline)––––FV2 (vehicle vs. piperine) <0.001* 0.005* 0.450 <0.001* FV3 (piperine vs. wash‐out) 0.010* 0.5310.213 <0.001* EDL (150 Hz) FV1 (baseline)––––FV2 (vehicle vs. piperine)0.382 0.003* 0.045# 0.042# FV3 (piperine vs. wash‐out)0.8060.0530.2880.717 Soleus (80 Hz) FV1 (baseline)––––FV2 (vehicle vs. piperine)0.697 0.002* 0.162 0.002* FV3 (piperine vs. wash‐out) 0.031# 0.3550.1720.095 Note: Values in bold with * and # indicate that muscles exposed to piperine increased or decreased more, respectively, relative to baseline than the opposite treatment (P ≤ 0.05) using paired t tests; n = 5 pairs of EDL muscles and n = 6 pairs of soleus muscles. P values from paired t tests comparing Hill estimates between treatments from the three low‐ and high‐frequency force–velocity tests (FV1–3) presented in Tables A5 and A6 Note: Values in bold with * and # indicate that muscles exposed to piperine increased or decreased more, respectively, relative to baseline than the opposite treatment (P ≤ 0.05) using paired t tests; n = 5 pairs of EDL muscles and n = 6 pairs of soleus muscles. Table A8Normalised Hill estimates from the three low‐frequency force–velocity tests (FV1‐3) F max (N cm−2) V max (L o s−1) P max (mW g−1)Incubation sequence a b a b a b EDL (60 Hz) FV113.18 ± 2.5913.24 ± 2.543.70 ± 0.293.35 ± 0.27112.74 ± 29.10117.49 ± 29.08FV211.92 ± 2.3615.01 ± 2.223.58 ± 0.304.07 ± 0.31105.73 ± 27.07150.22 ± 27.00FV314.03 ± 2.4012.60 ± 2.604.46 ± 0.433.48 ± 0.24135.52 ± 27.25122.13 ± 26.40 Soleus (20 Hz) FV111.98 ± 3.9613.33 ± 3.442.78 ± 0.832.15 ± 0.6616.82 ± 6.0520.98 ± 8.21FV210.96 ± 3.4815.52 ± 3.572.46 ± 0.672.31 ± 0.5714.44 ± 5.6228.81 ± 10.78FV312.64 ± 3.1612.06 ± 3.152.65 ± 0.662.17 ± 0.3520.68 ± 6.8117.92 ± 8.57 Note: The table is based on the same Hill's estimates of low‐frequency maximal isometric force (F max), maximal unloaded shortening velocity (V max) and maximal contraction power (P max) as described above. In this table, we show F max, V max and P max normalised to physiological cross‐sectional area (PCSA) (cm2), estimated muscle length (mm) at optimal force production (L o) and muscle weight (g), respectively. PCSA was estimated by the approach described by Jakobsgaard et al. (2021). Muscle lengths at L o for both soleus and extensor digitorum longus (EDL) muscles are reused from Jakobsgaard et al. (2021), with muscle weight being measured in the present experiments. Data are shown as the mean ± SD. For information on statistical differences, refer to Tables A5 and A7. Normalised Hill estimates from the three low‐frequency force–velocity tests (FV1‐3) Note: The table is based on the same Hill's estimates of low‐frequency maximal isometric force (F max), maximal unloaded shortening velocity (V max) and maximal contraction power (P max) as described above. In this table, we show F max, V max and P max normalised to physiological cross‐sectional area (PCSA) (cm2), estimated muscle length (mm) at optimal force production (L o) and muscle weight (g), respectively. PCSA was estimated by the approach described by Jakobsgaard et al. (2021). Muscle lengths at L o for both soleus and extensor digitorum longus (EDL) muscles are reused from Jakobsgaard et al. (2021), with muscle weight being measured in the present experiments. Data are shown as the mean ± SD. For information on statistical differences, refer to Tables A5 and A7. Table A9Normalised Hill estimates from the three high‐frequency force–velocity tests (FV1–3) F max (N cm−2) V max (L o s−1) P max (mW g−1)Incubation sequence a b a b a b EDL (150 Hz) FV119.31 ± 2.9320.65 ± 1.777.19 ± 0.226.99 ± 0.22283.73 ± 55.81305.28 ± 34.13FV217.54 ± 2.8518.34 ± 2.287.14 ± 0.167.30 ± 0.15271.49 ± 50.42285.60 ± 34.65FV316.66 ± 2.7917.73 ± 2.477.40 ± 0.167.08 ± 0.17259.78 ± 49.29279.37 ± 35.38 Soleus (80 Hz) FV120.15 ± 3.9521.91 ± 4.393.09 ± 0.383.21 ± 0.7545.74 ± 9.3357.81 ± 16.69FV219.14 ± 3.3920.94 ± 4.043.07 ± 0.463.47 ± 0.7743.86 ± 9.1961.07 ± 16.32FV317.58 ± 2.7620.53 ± 4.143.32 ± 0.503.28 ± 0.6945.70 ± 9.4254.63 ± 17.12 Note: The table is based on the same Hill's estimates of high‐frequency maximal isometric force (F max), maximal unloaded shortening velocity (V max) and maximal contraction power (P max) as described above. In this table, we show F max V max, and P max normalised to physiological cross‐sectional area (PCSA) (cm2), estimated muscle length (mm) at optimal force production (L o) and muscle weight (g), respectively, as described in Table A8. Data are shown as the mean ± SD. For information on statistical differences, we refer to Tables A6 and A7. Normalised Hill estimates from the three high‐frequency force–velocity tests (FV1–3) Note: The table is based on the same Hill's estimates of high‐frequency maximal isometric force (F max), maximal unloaded shortening velocity (V max) and maximal contraction power (P max) as described above. In this table, we show F max V max, and P max normalised to physiological cross‐sectional area (PCSA) (cm2), estimated muscle length (mm) at optimal force production (L o) and muscle weight (g), respectively, as described in Table A8. Data are shown as the mean ± SD. For information on statistical differences, we refer to Tables A6 and A7. Handling Editors: Karyn Hamilton & Christopher Sundberg The peer review history is available in the supporting Information section of this article (https://doi.org/10.1113/JP290962#support‐information‐section). This article was first published as a preprint. Kruse DZ, Herskind J, Kuehn MN, Klotz AJ, Hessel AL, Overgaard K. 2026. Piperine activates the thick filament of resting rat skeletal muscle, enhancing dynamic contractility in a fibre‐type‐dependent manner. bioRxiv. https://doi.org/10.1101/2025.11.24.689918. Data availability statement The data that support the findings of this study are available in the supporting information and upon request from the corresponding author. References Associated Data Supplementary Materials Peer Review History Supplementary Material Data Availability Statement The data that support the findings of this study are available in the supporting information and upon request from the corresponding author.